DGE	Genes	Process~name	num_of_Genes	gene_group	percentage%	P-value	Benjamini and Hochberg (FDR)	 Hommel singlewise process	Bonferroni single-step process	Hommel singlewise process	Hochberg step-up process	Benjamini and Yekutieli
down	TGFB1I1; SLIT3; GDF11; NTRK1; APP; SERPINE2; INHBA; PTHLH; LIF; FOSL1; IGFBP6; NOTCH1; CDH13; TGFB2; SOX4; IL24; DHRS2; PKD2; PTPRK; PTPN14; PDPN; P3H3; SFRP1; PTPRU; PROX1; E2F7; DLC1; BTG4; ADAMTS1; FBXO2; SCIN;	GO:0008285~negative regulation of cell population proliferation	31	396	7.82828282828283	0	0	0	0	0	0	0
down	TLL1; INHBA; MDK; PGF; FOXL2; HSPG2; BNC1; TTLL7; ARHGAP22; ARHGEF28; OSR1; MYCBPAP; TWIST2; PTPRU; CFAP54; MMP19; RBM24; CADM1; DLX1; DLX2; NR2F2; FOXA2; ETV5; FSTL3; ETV4; CAV1; SOX4; FOXC2; NKX3-2; FOXD1; FOXD2; POU2F2; FSTL1; FOXE1; ONECUT2;	GO:0030154~cell differentiation	35	572	6.11888111888112	0	0	0	0	0	0	0
down	BMPR1B; SHOX2; COL11A1; RUNX2;	GO:0002063~chondrocyte development	4	17	23.5294117647059	0.00011000038332476	0.00211789470429502	0.285340994344427	0.300741048009893	0.198000689984568	0.285230993961102	0.0179828735564457
down	SNAI2; NOTCH1; CAV1; NTRK2;	GO:2000811~negative regulation of anoikis	4	17	23.5294117647059	0.00011000038332476	0.00211789470429502	0.285340994344427	0.300741048009893	0.198000689984568	0.285230993961102	0.0179828735564457
up	UGT1A9; UGT1A1; UGT1A3; UGT1A7; UGT1A8; UGT1A6; UGT1A10;	GO:0052696~flavonoid glucuronidation	7	7	100	0.00011493820899932	0.058401381083769	0.524692924081926	0.525612429753921	0.523543541991933	0.524692924081926	0.525919020768439
down	TBX1; COL2A1; COL11A1; PRRX1; SIX1; SIX4;	GO:0042472~inner ear morphogenesis	6	57	10.5263157894737	0.00011934403546753	0.00225025236529829	0.309220395896394	0.326286592968252	0.207780108141588	0.309101051860926	0.0191067118082822
down	TBX1; TNC; DLX1; DLX2; RUNX2; SHH;	GO:0042475~odontogenesis of dentin-containing tooth	6	57	10.5263157894737	0.00011934403546753	0.00225025236529829	0.309220395896394	0.326286592968252	0.207780108141588	0.309101051860926	0.0191067118082822
down	SH3PXD2B; BMPR1B; SIPA1L3; TGFB2; MAB21L1;	GO:0001654~eye development	5	35	14.2857142857143	0.00012123413547771	0.0022547899754834	0.313875176751792	0.33145412639606	0.209822788649225	0.313753942616314	0.019145240291328
down	TERT; SNAI2; COL2A1; CSF2; GDNF;	GO:2001240~negative regulation of extrinsic apoptotic signaling pathway in absence of ligand	5	35	14.2857142857143	0.00012123413547771	0.0022547899754834	0.313875176751792	0.33145412639606	0.209822788649225	0.313753942616314	0.019145240291328
down	COL2A1; CD44; PRRX1; EVC; DLX2; SATB2;	GO:0051216~cartilage development	6	58	10.3448275862069	0.00013034537206801	0.00237935053717395	0.337203477539966	0.356364247233965	0.219371261190476	0.337203477539966	0.0202028740001514
down	NOTCH1; ISL1; TGFB2; TWIST1;	GO:0003203~endocardial cushion morphogenesis	4	18	22.2222222222222	0.00013315312077089	0.00237935053717395	0.344333970313522	0.364040632187614	0.222365711687387	0.343801357830439	0.0202028740001514
down	FSTL3; KIF26B; NODAL; MYO10;	GO:0022409~positive regulation of cell-cell adhesion	4	18	22.2222222222222	0.00013315312077089	0.00237935053717395	0.344333970313522	0.364040632187614	0.222365711687387	0.343801357830439	0.0202028740001514
down	BMPR1B; SEMA4F; ISL1; NRCAM;	GO:0031290~retinal ganglion cell axon guidance	4	18	22.2222222222222	0.00013315312077089	0.00237935053717395	0.344333970313522	0.364040632187614	0.222365711687387	0.343801357830439	0.0202028740001514
down	APOD; THBS1; MMP14; DLC1;	GO:0051895~negative regulation of focal adhesion assembly	4	18	22.2222222222222	0.00013315312077089	0.00237935053717395	0.344333970313522	0.364040632187614	0.222365711687387	0.343801357830439	0.0202028740001514
down	TBX1; ISL1; SIX1; SIX4;	GO:0060037~pharyngeal system development	4	18	22.2222222222222	0.00013315312077089	0.00237935053717395	0.344333970313522	0.364040632187614	0.222365711687387	0.343801357830439	0.0202028740001514
down	BMPR1B; GDNF; DLX1; ISL1; DLX2;	GO:0045597~positive regulation of cell differentiation	5	36	13.8888888888889	0.00013669662907589	0.00242680898632139	0.352813999644883	0.373728583893495	0.226096224491529	0.352813999644883	0.0206058398739849
down	THBS1; MAP1B; TWIST1; SFRP1; FEZ1; BMPR1B;	GO:0071363~cellular response to growth factor stimulus	6	59	10.1694915254237	0.00014213496277482	0.00243215002916778	0.366708203959036	0.388596988226359	0.231494801161483	0.366512732998217	0.0206511902391241
down	SERPINE1; SERPINE2; THBS1;	GO:0010757~negative regulation of plasminogen activation	3	6	50	0.00014233504194105	0.00243215002916778	0.367082073165981	0.389144004666845	0.231705902845681	0.366512732998217	0.0206511902391241
down	NOTCH1; DLX1; DLX2;	GO:0046533~negative regulation of photoreceptor cell differentiation	3	6	50	0.00014233504194105	0.00243215002916778	0.367082073165981	0.389144004666845	0.231705902845681	0.366512732998217	0.0206511902391241
down	CEP290; LHX1; OSR1;	GO:0048793~pronephros development	3	6	50	0.00014233504194105	0.00243215002916778	0.367082073165981	0.389144004666845	0.231705902845681	0.366512732998217	0.0206511902391241
down	SERPINE1; FAM20C; HTRA1;	GO:0097187~dentinogenesis	3	6	50	0.00014233504194105	0.00243215002916778	0.367082073165981	0.389144004666845	0.231705902845681	0.366512732998217	0.0206511902391241
down	ADAMTS3; CCBE1; ROBO1;	GO:1900748~positive regulation of vascular endothelial growth factor signaling pathway	3	6	50	0.00014233504194105	0.00243215002916778	0.367082073165981	0.389144004666845	0.231705902845681	0.366512732998217	0.0206511902391241
down	SERPINE1; IL24; PTPRK; SHH; SFRP1; PTPRU; DLC1; ROBO1;	GO:0030336~negative regulation of cell migration	8	116	6.89655172413793	0.00014682041199443	0.00249321121983089	0.377915740473664	0.401407006392773	0.23594040207505	0.377915740473664	0.0211696558968709
down	PDGFA; INHBA; HOXC13; TGFB2; VANGL2;	GO:0001942~hair follicle development	5	37	13.5135135135135	0.00015362369925475	0.00256101947416162	0.395273778182489	0.420007193762505	0.24181821301657	0.39496653078398	0.0217454103294401
down	WNT7A; COL2A1; HMGA2; OSR1; RUNX2;	GO:0002062~chondrocyte differentiation	5	37	13.5135135135135	0.00015362369925475	0.00256101947416162	0.395273778182489	0.420007193762505	0.24181821301657	0.39496653078398	0.0217454103294401
down	GDF11; POU2F2; AXL; RUNX2; LHX6;	GO:0048469~cell maturation	5	37	13.5135135135135	0.00015362369925475	0.00256101947416162	0.395273778182489	0.420007193762505	0.24181821301657	0.39496653078398	0.0217454103294401
down	GJC1; CAV1; SHH; TEAD2; NTRK2; HAS2;	GO:0001570~vasculogenesis	6	60	10	0.00015475283298926	0.00256420754783431	0.397714780782421	0.423094245392661	0.242672654344884	0.397714780782421	0.0217724800065248
down	RUNX2; SHH; SATB2; PTHLH;	GO:0002076~osteoblast development	4	19	21.0526315789474	0.00015963727033174	0.00261346285680836	0.410108147482259	0.436448297086997	0.246372706569311	0.409948510211927	0.0221907028725945
down	ITGA2; POSTN; SEMA6D; HAS2;	GO:0014911~positive regulation of smooth muscle cell migration	4	19	21.0526315789474	0.00015963727033174	0.00261346285680836	0.410108147482259	0.436448297086997	0.246372706569311	0.409948510211927	0.0221907028725945
down	TGFB2; PDPN; CDH13; CDH3; CDH26; CDH11; CDH10;	GO:0000902~cell morphogenesis	7	88	7.95454545454545	0.00016713748679952	0.00271996362446376	0.429041928614391	0.456953888909912	0.25204333009369	0.429041928614391	0.023094992323117
down	INHBA; KITLG; MMP14; FOXL2; MMP19;	GO:0001541~ovarian follicle development	5	38	13.1578947368421	0.00017210648921794	0.00276787730306984	0.441625251333257	0.470539141521873	0.25575385537308	0.44145314484404	0.023501823513662
down	AGRN; HSPG2; XYLT2; HS3ST2; GPC6;	GO:0006024~glycosaminoglycan biosynthetic process	5	38	13.1578947368421	0.00017210648921794	0.00276787730306984	0.441625251333257	0.470539141521873	0.25575385537308	0.44145314484404	0.023501823513662
down	BMPR1B; WNT7A; COL2A1; COL11A1;	GO:0001502~cartilage condensation	4	20	20	0.00018972562172237	0.00300727343361224	0.486456494096156	0.518709849788959	0.269052243547352	0.486266768474434	0.0255345167994594
down	SNAI2; PTHLH; NKX3-2; ADAMTS7;	GO:0032331~negative regulation of chondrocyte differentiation	4	20	20	0.00018972562172237	0.00300727343361224	0.486456494096156	0.518709849788959	0.269052243547352	0.486266768474434	0.0255345167994594
down	FSTL3; INHBA; KITLG; MMP14; TGFB2; SFRP1; SIX4;	GO:0008584~male gonad development	7	90	7.77777777777778	0.0001902919912271	0.00300727343361224	0.487528081523855	0.520258304014917	0.269484730669422	0.487528081523855	0.0255345167994594
up	S100A8; S100A9; EDN3; LGALS3; EDN2; XCL1; NCKAP1L; CXADR; S100A12; XCL2; CCL8; CCL22; CX3CL1; CCL21; CCL14; CCL17; CCL11; CCL18; CCL19; CXCL13; CCL2;	GO:0030593~neutrophil chemotaxis	21	76	27.6315789473684	0.00020011603507974	0.0835395906223445	0.913329584103955	0.915130628419673	0.832409178360325	0.913329584103955	0.752294875227021
down	ANTXR2; ANTXR1; KCNU1;	GO:0022414~reproductive process	3	7	42.8571428571429	0.00020149581103434	0.00313005424640855	0.516030772058962	0.550889547367904	0.277135690914322	0.515627780436893	0.0265770388035968
down	TGFB2; SIX1; SIX4;	GO:0048699~generation of neurons	3	7	42.8571428571429	0.00020149581103434	0.00313005424640855	0.516030772058962	0.550889547367904	0.277135690914322	0.515627780436893	0.0265770388035968
down	LHX1; OSR1; FOXA2;	GO:2000543~positive regulation of gastrulation	3	7	42.8571428571429	0.00020149581103434	0.00313005424640855	0.516030772058962	0.550889547367904	0.277135690914322	0.515627780436893	0.0265770388035968
down	SNAI2; NOTCH1; HMGA2; TGFB2; LOXL2;	GO:0001837~epithelial to mesenchymal transition	5	40	12.5	0.00021411650542435	0.00329227728833942	0.547710020875501	0.585394525830188	0.284774952214393	0.547710020875501	0.027954461602317
down	NEFL; DLX1; DLX2; CDK5R2; FEZ1; LHX5;	GO:0021766~hippocampus development	6	64	9.375	0.00021434724115743	0.00329227728833942	0.548085895639551	0.586025357324416	0.284867483498226	0.548085895639551	0.027954461602317
up	MPHOSPH10; NOP56; DKC1; RPP40; SNU13; NOLC1; WDR43; UTP15; EMG1; RRP36; UTP14A; WDR12; NOL11; UTP3; DDX21; DCAF13; IMP3; LYAR; UTP6; NOB1; WDR3; PA2G4; NOP58; SBDS; POP5; DDX10; EBNA1BP2; POP4; MRTO4; ESF1; PIH1D2;	GO:0006364~rRNA processing	31	139	22.3021582733813	0.00021921606985964	0.0835395906223445	1	1	0.865146772866244	0.999999999678419	0.752294875227021
down	ITGA3; LOX; SMURF2; DKK3;	GO:0017015~regulation of transforming growth factor beta receptor signaling pathway	4	21	19.047619047619	0.00022369634326091	0.0034166804607561	0.571767853374899	0.611585802475342	0.289569147653437	0.571767853374899	0.0290107589314775
down	FN1; FGD1; FGD6; PDPN; BVES; FBLIM1; FERMT2; DLC1; MYO10;	GO:0008360~regulation of cell shape	9	159	5.66037735849057	0.00023538937841172	0.00357530311432025	0.601419861841948	0.643554560577646	0.29541366990671	0.601419861841948	0.0303576111222154
down	FOXE1; TBX1; SHH; SIX1;	GO:0030878~thyroid gland development	4	22	18.1818181818182	0.00026183245792721	0.00393674909055491	0.668720097546103	0.715849939973002	0.308669471845724	0.668720097546103	0.0334266198292737
down	MMP14; SNRPN; STEAP2; MMP19; FOXC2;	GO:0009725~response to hormone	5	42	11.9047619047619	0.00026350588279866	0.00393674909055491	0.672730518784991	0.720425083571549	0.309445193824415	0.672467012902192	0.0334266198292737
down	THBS1; FOSL1; TGFB2; CAV1; DSG2;	GO:0032570~response to progesterone	5	42	11.9047619047619	0.00026350588279866	0.00393674909055491	0.672730518784991	0.720425083571549	0.309445193824415	0.672467012902192	0.0334266198292737
up	TRAV19; NCR3; TYROBP; LILRA1; IGKV1-5; IGKV3-20; IGKV3-15; IGLV1-47; IGLV2-14; IGLV2-23; IGLV3-1; IGLV3-25; IGHV3-23; IGKC; TRBC1; CD3D; IGKV3-11; TRBV7-9; CD1A; IGKV4-1; CD3G; IGLC2; IGLC3; CD8B; CD19; KLRC1; CD1B; CD1C; CD40LG; FCGR2B; ICAM3; CXADR; IGLV3-21; COLEC12; TREML2; CD300LG; LILRB2; LILRB1; RAET1E; CD300LF; CD300A; VTCN1;	GO:0050776~regulation of immune response	42	216	19.4444444444444	0.00026762505226329	0.0941422587692356	1	1	0.935474069446575	0.999999999678419	0.847774549609164
down	MELTF; FSCN1; PDPN;	GO:0090091~positive regulation of extracellular matrix disassembly	3	8	37.5	0.00027455120795294	0.00405247654977559	0.700380131487961	0.75062300254335	0.314931810736195	0.700105580280008	0.0344092523756197
down	SH3PXD2B; FOXE1; TGFB2;	GO:1904888~cranial skeletal system development	3	8	37.5	0.00027455120795294	0.00405247654977559	0.700380131487961	0.75062300254335	0.314931810736195	0.700105580280008	0.0344092523756197
down	PXN; TGFB2; LTBP2; PTPRK; FERMT2; FUT8; TGFB1I1;	GO:0007179~transforming growth factor beta receptor signaling pathway	7	96	7.29166666666667	0.00027569884354727	0.00405247654977559	0.702756352202013	0.753760638258259	0.315569789446867	0.702756352202013	0.0344092523756197
down	TBX1; SHOX2; PDGFA; PRRX1;	GO:0002053~positive regulation of mesenchymal cell proliferation	4	23	17.3913043478261	0.00030442133752406	0.00442706349356803	0.775665568011314	0.832287936790789	0.329079465863513	0.77536114667379	0.0375898399810631
down	DSCAM; LHX1; SDK2; FJX1;	GO:0010842~retina layer formation	4	23	17.3913043478261	0.00030442133752406	0.00442706349356803	0.775665568011314	0.832287936790789	0.329079465863513	0.77536114667379	0.0375898399810631
down	TBX1; RET; TNC; PTK7; TEAD2; OSR1;	GO:0071300~cellular response to retinoic acid	6	69	8.69565217391304	0.00031274930408575	0.00452410898079609	0.796259728202339	0.855056597370461	0.332739454945963	0.796259728202339	0.0384138454061235
down	NOTCH1; VEGFC; TWIST1; SFRP1; TWIST2;	GO:0045668~negative regulation of osteoblast differentiation	5	44	11.3636363636364	0.00032109198664986	0.00459615440576304	0.817179106023915	0.87786549150074	0.336248473707233	0.816858014037265	0.0390255773136984
down	KRT8; INHBA; TGFB2; MLLT11; TNFRSF12A;	GO:0097191~extrinsic apoptotic signaling pathway	5	44	11.3636363636364	0.00032109198664986	0.00459615440576304	0.817179106023915	0.87786549150074	0.336248473707233	0.816858014037265	0.0390255773136984
up	UGT1A9; UGT1A1; UGT1A3; UGT1A7; UGT1A8; UGT1A10; UGT1A6;	GO:0052697~xenobiotic glucuronidation	7	9	77.7777777777778	0.00032392665181968	0.0987544385847609	1	1	0.990431034614329	0.999999999678419	0.88930838061069
up	FCN1; IGKV1-5; IGKV3-20; IGKV3-15; IGLV1-47; IGLV2-14; IGLV2-23; IGLV3-1; IGLV3-25; IGHV3-23; IGKC; IGHG2; IGHG3; IGHG4; C1QA; C1QB; C1QC; IGKV3-11; IGKV4-1; IGLC2; IGLC3; IGLV3-21; COLEC10;	GO:0006956~complement activation	23	92	25	0.0003505799024962	0.100200118382197	1	1	0.999999999678419	0.999999999678419	0.902327088204638
down	TBX1; PTK7; SIX1; VANGL2;	GO:0090103~cochlea morphogenesis	4	24	16.6666666666667	0.00035175421542454	0.00498384565025999	0.894510969824628	0.961696024970717	0.349415410360178	0.894510969824628	0.0423174324822255
down	DSCAM; LPXN; MDK; TNC; CDH13;	GO:0007162~negative regulation of cell adhesion	5	45	11.1111111111111	0.00035322420025329	0.00498384565025999	0.897895917043887	0.96571496349252	0.35004518245102	0.897895917043887	0.0423174324822255
down	TBX3; CAV1; OSR1;	GO:0030857~negative regulation of epithelial cell differentiation	3	9	33.3333333333333	0.0003627597967819	0.00498384565025999	0.92177264362283	0.991785284401738	0.353884442849061	0.91995884463892	0.0423174324822255
down	ADAMTS3; SERPINH1; P3H3;	GO:0032964~collagen biosynthetic process	3	9	33.3333333333333	0.0003627597967819	0.00498384565025999	0.92177264362283	0.991785284401738	0.353884442849061	0.91995884463892	0.0423174324822255
down	FN1; COL16A1; FERMT2;	GO:0033622~integrin activation	3	9	33.3333333333333	0.0003627597967819	0.00498384565025999	0.92177264362283	0.991785284401738	0.353884442849061	0.91995884463892	0.0423174324822255
down	FBN1; MFAP2; FOXL2;	GO:0048048~embryonic eye morphogenesis	3	9	33.3333333333333	0.0003627597967819	0.00498384565025999	0.92177264362283	0.991785284401738	0.353884442849061	0.91995884463892	0.0423174324822255
down	PXDN; LAMB3; LAMB1;	GO:0070831~basement membrane assembly	3	9	33.3333333333333	0.0003627597967819	0.00498384565025999	0.92177264362283	0.991785284401738	0.353884442849061	0.91995884463892	0.0423174324822255
down	PCSK9; OSR1; HECW1;	GO:2000650~negative regulation of sodium ion transmembrane transporter activity	3	9	33.3333333333333	0.0003627597967819	0.00498384565025999	0.92177264362283	0.991785284401738	0.353884442849061	0.91995884463892	0.0423174324822255
down	TBX3; TBX1; NOTCH1; ISL1; SIX1;	GO:0003151~outflow tract morphogenesis	5	46	10.8695652173913	0.0003877284164786	0.00524776975570548	0.982891535773265	1	0.363539064087819	0.969996934992558	0.0445583908297294
down	APP; AGRN; LAMC2; EGFLAM; MAP1B;	GO:0016358~dendrite development	5	46	10.8695652173913	0.0003877284164786	0.00524776975570548	0.982891535773265	1	0.363539064087819	0.969996934992558	0.0445583908297294
down	APP; NR2F2; NOTCH1; SHH; DLC1;	GO:0030900~forebrain development	5	46	10.8695652173913	0.0003877284164786	0.00524776975570548	0.982891535773265	1	0.363539064087819	0.969996934992558	0.0445583908297294
down	SERPINB7; VIM; ITGA2; LARP6;	GO:0032967~positive regulation of collagen biosynthetic process	4	25	16	0.0004041257161298	0.00541607699950427	1	1	0.369775030258767	0.969996934992558	0.045987474097056
down	COL11A1; ISL1; PROX1; FOXC2;	GO:0055010~ventricular cardiac muscle tissue morphogenesis	4	25	16	0.0004041257161298	0.00541607699950427	1	1	0.369775030258767	0.969996934992558	0.045987474097056
down	CDH13; PRKD1; PROX1; CCL26; PGF; VEGFC;	GO:0001938~positive regulation of endothelial cell proliferation	6	73	8.21917808219178	0.00041441864095292	0.00550009982701606	1	1	0.373604005704925	0.969996934992558	0.0467009051660961
down	NTRK2; RET; EPHB4; IGF1R; AXL; NTRK1;	GO:0033674~positive regulation of kinase activity	6	73	8.21917808219178	0.00041441864095292	0.00550009982701606	1	1	0.373604005704925	0.969996934992558	0.0467009051660961
up	SRPX2; ANXA9; EGFR; CSTA; ANXA1; JUP; CRISP2; CD24; ICAM3; ITGA8; RAB10; CX3CL1; DSG1; FOXF1; DLG1; TRIM29; COL19A1; TTYH1; CRNN; CTNNA3; BAIAP2; LRRC1; CTNND1; DSG3; CDH12; PKP3; DSC3; DSC2; CDH19; PKP1; DSP; ICOS;	GO:0098609~cell-cell adhesion	32	152	21.0526315789474	0.0004224115600403	0.112873386943919	1	1	0.999999999678419	0.999999999678419	1
down	HOXC11; GDNF; SIX1;	GO:0001759~organ induction	3	10	30	0.00046732818822559	0.00611327878760175	1	1	0.392088349921271	0.969996934992558	0.0519073583921811
down	ITGA3; FSTL3; FSTL1;	GO:0030510~regulation of BMP signaling pathway	3	10	30	0.00046732818822559	0.00611327878760175	1	1	0.392088349921271	0.969996934992558	0.0519073583921811
down	MMP14; MMP16; HMGA2;	GO:0035988~chondrocyte proliferation	3	10	30	0.00046732818822559	0.00611327878760175	1	1	0.392088349921271	0.969996934992558	0.0519073583921811
down	ONECUT2; NOTCH1; PKD2; PCSK9; PROX1; NODAL;	GO:0001889~liver development	6	75	8	0.00047406956801354	0.0061719342807097	1	1	0.394425880587271	0.969996934992558	0.0524053974655175
down	SNAI2; SHOX2; TNC; LOX; RUNX2; TWIST1; SFRP1;	GO:0001649~osteoblast differentiation	7	106	6.60377358490566	0.00048425545992225	0.00627466553283151	1	1	0.397682171555056	0.969996934992558	0.0532776802628895
up	PLA2G4B; PLA2G2A; PLA2G5; PLA2G4A; PLA2G4F; PLA2G4D; SERAC1; PLA2G12A; PLA2G3;	GO:0036148~phosphatidylglycerol acyl-chain remodeling	9	18	50	0.0005158232735255	0.112873386943919	1	1	0.999999999678419	0.999999999678419	1
up	MRPS22; MRPS10; MRPS35; MRPS15; MRPS6; MRPS9; MRPL58; MRPL51; MRPL21; MRPL50; GADD45GIP1; MRPL30; CHCHD1; MRPL48; MRPL57; MRPL20; MRPL1; MRPL18; MRPL47; MRPL40; MRPS18A; MRPL39;	GO:0070125~mitochondrial translational elongation	22	89	24.7191011235955	0.00053055251504785	0.112873386943919	1	1	0.999999999678419	0.999999999678419	1
up	MRPS22; MRPS10; MRPS35; MRPS15; MRPS6; MRPS9; MRPL58; MRPL51; MRPL21; MRPL50; GADD45GIP1; MRPL30; CHCHD1; MRPL48; MRPL57; MRPL20; MRPL1; MRPL18; MRPL47; MRPL40; MRPS18A; MRPL39;	GO:0070126~mitochondrial translational termination	22	89	24.7191011235955	0.00053055251504785	0.112873386943919	1	1	0.999999999678419	0.999999999678419	1
up	UGT1A9; UGT2B7; UGT1A6; UGT1A1; UGT1A4; UGT1A3; UGT1A7; UGT1A10;	GO:0052695~cellular glucuronidation	8	14	57.1428571428571	0.00054301651274135	0.112873386943919	1	1	0.999999999678419	0.999999999678419	1
down	SIX1; NR2F2; SIX4; IGF1R; SPOCK1;	GO:0048856~anatomical structure development	5	50	10	0.00055173553393084	0.0071153063668251	1	1	0.42033478177734	0.969996934992558	0.0604154939575151
down	TGFB1I1; VEGFC; TBX18;	GO:0016331~morphogenesis of embryonic epithelium	3	11	27.2727272727273	0.0005894123468928	0.00742124555973683	1	1	0.432740051614781	0.969996934992558	0.0630131990327181
down	TBX1; LHX1; FOXC2;	GO:0048703~embryonic viscerocranium morphogenesis	3	11	27.2727272727273	0.0005894123468928	0.00742124555973683	1	1	0.432740051614781	0.969996934992558	0.0630131990327181
down	SERPINE2; LIF; NOTCH1;	GO:0048711~positive regulation of astrocyte differentiation	3	11	27.2727272727273	0.0005894123468928	0.00742124555973683	1	1	0.432740051614781	0.969996934992558	0.0630131990327181
down	BMPR1B; THBS1; SFRP1;	GO:1902043~positive regulation of extrinsic apoptotic signaling pathway via death domain receptors	3	11	27.2727272727273	0.0005894123468928	0.00742124555973683	1	1	0.432740051614781	0.969996934992558	0.0630131990327181
down	RET; INHBA; SRPX;	GO:2001241~positive regulation of extrinsic apoptotic signaling pathway in absence of ligand	3	11	27.2727272727273	0.0005894123468928	0.00742124555973683	1	1	0.432740051614781	0.969996934992558	0.0630131990327181
down	FOXE1; NOTCH1; TGFB2; SHH;	GO:0031069~hair follicle morphogenesis	4	28	14.2857142857143	0.00059445968455829	0.00742124555973683	1	1	0.43455002941211	0.969996934992558	0.0630131990327181
down	SLC26A6; SLC4A3; SLC9A5; SLC9A3;	GO:0051453~regulation of intracellular pH	4	28	14.2857142857143	0.00059445968455829	0.00742124555973683	1	1	0.43455002941211	0.969996934992558	0.0630131990327181
down	COL4A1; COL5A2; MMP2; COL16A1; NTRK2;	GO:0071230~cellular response to amino acid stimulus	5	51	9.80392156862745	0.00059981925696517	0.00745411749337628	1	1	0.436233771151627	0.969996934992558	0.0632923119768108
down	COL4A1; EDNRA; SHH; FOXC2;	GO:0001569~branching involved in blood vessel morphogenesis	4	29	13.7931034482759	0.00066998425743958	0.00821406708448348	1	1	0.452187018147411	0.969996934992558	0.0697449828194353
down	COL2A1; MMP14; MMP16; RUNX2;	GO:0001958~endochondral ossification	4	29	13.7931034482759	0.00066998425743958	0.00821406708448348	1	1	0.452187018147411	0.969996934992558	0.0697449828194353
down	NOTCH1; PKD2; PROX1; SEMA3C;	GO:0021915~neural tube development	4	29	13.7931034482759	0.00066998425743958	0.00821406708448348	1	1	0.452187018147411	0.969996934992558	0.0697449828194353
down	APP; SERPINE1; TFPI2; COL7A1; SPOCK1; SERPINB7; SERPINE2; SERPINH1;	GO:0010951~negative regulation of endopeptidase activity	8	148	5.40540540540541	0.00068963024266122	0.00841718340819544	1	1	0.455357548207176	0.969996934992558	0.0714696271840276
down	KIF3C; DYNC1H1; KIF26B; WDR63; WDR78; DNAH5;	GO:0007018~microtubule-based movement	6	81	7.40740740740741	0.00069380466609025	0.00843049758707008	1	1	0.456060470495666	0.969996934992558	0.0715826768057698
down	FOSL1; NR2F2; PKD2;	GO:0060674~placenta blood vessel development	3	12	25	0.00073011887200435	0.0087550219125435	1	1	0.46216524597876	0.969996934992558	0.0743381867464409
down	TFPI2; PKD2; HAS2;	GO:0071498~cellular response to fluid shear stress	3	12	25	0.00073011887200435	0.0087550219125435	1	1	0.46216524597876	0.969996934992558	0.0743381867464409
down	TERT; TBX3; HMGA2;	GO:2000648~positive regulation of stem cell proliferation	3	12	25	0.00073011887200435	0.0087550219125435	1	1	0.46216524597876	0.969996934992558	0.0743381867464409
down	LHX1; LAMC2; EGFLAM; AGRN;	GO:0008045~motor neuron axon guidance	4	30	13.3333333333333	0.00075205618150353	0.00886259310444252	1	1	0.465770004858829	0.969996934992558	0.0752515650831038
down	HRH1; CAV1; ADRA1B; ADRA1D;	GO:0045907~positive regulation of vasoconstriction	4	30	13.3333333333333	0.00075205618150353	0.00886259310444252	1	1	0.465770004858829	0.969996934992558	0.0752515650831038
down	KCNK2; NTRK1; APOD; FLRT3;	GO:0048678~response to axon injury	4	30	13.3333333333333	0.00075205618150353	0.00886259310444252	1	1	0.465770004858829	0.969996934992558	0.0752515650831038
down	AGRN; FSCN1; PLPPR5; TENM2;	GO:0051491~positive regulation of filopodium assembly	4	30	13.3333333333333	0.00075205618150353	0.00886259310444252	1	1	0.465770004858829	0.969996934992558	0.0752515650831038
down	LCAT; CAV1; PCSK9; DISP3; LIMA1; LIPG;	GO:0042632~cholesterol homeostasis	6	83	7.2289156626506	0.00078226896819266	0.00917907021046675	1	1	0.470925918851986	0.969996934992558	0.0779387467308043
down	TBX1; LHX1; SHH; SIX1;	GO:0007389~pattern specification process	4	31	12.9032258064516	0.00084098149470368	0.00958521295717571	1	1	0.480639030581443	0.969996934992558	0.0813872721202504
down	PXN; CDH13; LOXL2; TGFB1I1;	GO:0043542~endothelial cell migration	4	31	12.9032258064516	0.00084098149470368	0.00958521295717571	1	1	0.480639030581443	0.969996934992558	0.0813872721202504
down	HOXC6; DLX1; NKX3-2; SHH;	GO:0048706~embryonic skeletal system development	4	31	12.9032258064516	0.00084098149470368	0.00958521295717571	1	1	0.480639030581443	0.969996934992558	0.0813872721202504
up	PRSS38; PRSS37; TRABD2B; ADAMDEC1; KLK10; TMPRSS11D; KLK8; HP; HPR; LTF; CTSG; CPA3; GZMH; AGA; ENDOU; KEL; PRSS3; GGT5; MMP12; KLK7; GZMK; TMPRSS3; RHBDL3; ADAMTSL3; HTRA3; TMPRSS15; ESPL1; PSMD6; PRSS8; MMEL1; CPZ; PM20D1; GGT6; CASP12; TMPRSS11A; TMPRSS11F; ASRGL1; OVCH1; ADAMTSL2; DPP10; ADGB; ADAMTS14; ATG4A; CAPNS2; PRSS27; TMPRSS13; ADAM33; PRSS22; ADAMTS10; TMPRSS4; RHBDL2; KLK11; FBXO3; KLK12; KLK13; TMPRSS11E; ADAMTS5; KLK5; AFG3L2; SPCS1; PGA5; TPSAB1; CPO; TPSB2; PGA3; PGC; CPA4; TPSD1; PRSS21;	GO:0006508~proteolysis	69	436	15.8256880733945	0.00086881976618546	0.165546366281923	1	1	0.999999999678419	0.999999999678419	1
down	BMPR1B; FSTL1; RUNX2; SMURF2; TGFB2; NODAL;	GO:0030509~BMP signaling pathway	6	85	7.05882352941176	0.00087919323022955	0.00958521295717571	1	1	0.487073049547175	0.969996934992558	0.0813872721202504
down	SLIT3; NOTCH1; TGFB2;	GO:0003181~atrioventricular valve morphogenesis	3	13	23.0769230769231	0.00089050625132502	0.00958521295717571	1	1	0.488887931977441	0.969996934992558	0.0813872721202504
down	MDK; CDH3; HAS2;	GO:0010838~positive regulation of keratinocyte proliferation	3	13	23.0769230769231	0.00089050625132502	0.00958521295717571	1	1	0.488887931977441	0.969996934992558	0.0813872721202504
down	FLRT2; COL4A1; CAV1;	GO:0071711~basement membrane organization	3	13	23.0769230769231	0.00089050625132502	0.00958521295717571	1	1	0.488887931977441	0.969996934992558	0.0813872721202504
down	PTK7; SFRP1; VANGL2;	GO:0090179~planar cell polarity pathway involved in neural tube closure	3	13	23.0769230769231	0.00089050625132502	0.00958521295717571	1	1	0.488887931977441	0.969996934992558	0.0813872721202504
down	LPXN; PXN; PTPN14;	GO:1903506~regulation of nucleic acid-templated transcription	3	13	23.0769230769231	0.00089050625132502	0.00958521295717571	1	1	0.488887931977441	0.969996934992558	0.0813872721202504
down	WNT7A; TGFB1I1; GRK5; PKD2; AMOTL1; FERMT2; MARK1; DKK3; CTNND2;	GO:0016055~Wnt signaling pathway	9	194	4.63917525773196	0.00092498231427129	0.00989166260732446	1	1	0.49474793797143	0.969996934992558	0.0839893114467883
down	NTRK1; MMP2; EPHB4; EFNB1; EFNB3; ARHGEF28;	GO:0048013~ephrin receptor signaling pathway	6	86	6.97674418604651	0.00093099347055192	0.00989166260732446	1	1	0.495591846920322	0.969996934992558	0.0839893114467883
down	MAP1B; NCKAP5L; MTCL1; NAV1;	GO:0001578~microtubule bundle formation	4	32	12.5	0.00093706679418326	0.00989166260732446	1	1	0.496645400917128	0.969996934992558	0.0839893114467883
down	LIF; AXL; FOXC2; SEMA3C;	GO:0001974~blood vessel remodeling	4	32	12.5	0.00093706679418326	0.00989166260732446	1	1	0.496645400917128	0.969996934992558	0.0839893114467883
down	WNT7A; LHX1; SHH; BMPR1B;	GO:0009953~dorsal/ventral pattern formation	4	32	12.5	0.00093706679418326	0.00989166260732446	1	1	0.496645400917128	0.969996934992558	0.0839893114467883
down	PDGFA; CSF3; TGFB2; NTRK2; NTRK1; IGF1R;	GO:0014068~positive regulation of phosphatidylinositol 3-kinase signaling	6	87	6.89655172413793	0.0009851091639389	0.0103588017469575	1	1	0.504567525914313	0.969996934992558	0.087955752301592
down	SFRP1; NODAL; VANGL2;	GO:0048546~digestive tract morphogenesis	3	14	21.4285714285714	0.00107158608961866	0.0110974104887023	1	1	0.519030223765008	0.969996934992558	0.0942272197090821
down	VEGFC; ARTN; PGF;	GO:0050930~induction of positive chemotaxis	3	14	21.4285714285714	0.00107158608961866	0.0110974104887023	1	1	0.519030223765008	0.969996934992558	0.0942272197090821
down	NOTCH1; TGFB2; FOXC2;	GO:0060038~cardiac muscle cell proliferation	3	14	21.4285714285714	0.00107158608961866	0.0110974104887023	1	1	0.519030223765008	0.969996934992558	0.0942272197090821
down	LIF; NR2F2; E2F7;	GO:0060707~trophoblast giant cell differentiation	3	14	21.4285714285714	0.00107158608961866	0.0110974104887023	1	1	0.519030223765008	0.969996934992558	0.0942272197090821
down	THBS1; COL4A2; THBS2; TGFB2; HSPG2; ADAMTS1;	GO:0016525~negative regulation of angiogenesis	6	89	6.74157303370786	0.00110056201257835	0.0113117915127414	1	1	0.523867517987297	0.969996934992558	0.0960475117379438
down	SERPINE2; LAMA1; LAMA3; FRMD5; AJUBA; AMOTL1;	GO:0030334~regulation of cell migration	6	89	6.74157303370786	0.00110056201257835	0.0113117915127414	1	1	0.523867517987297	0.969996934992558	0.0960475117379438
down	GDF11; VIM; TGFB2; NODAL; INHBA;	GO:0060395~SMAD protein signal transduction	5	59	8.47457627118644	0.00110563568293198	0.0113213781166144	1	1	0.524832744006591	0.969996934992558	0.096128910820218
down	COL4A1; TNC; COL4A5; AGRN;	GO:0007528~neuromuscular junction development	4	34	11.7647058823529	0.00115194448374001	0.0117078669834393	1	1	0.53231329037209	0.969996934992558	0.0994105566966596
down	MMP2; PXN; PKD2; PTPRK;	GO:0034614~cellular response to reactive oxygen species	4	34	11.7647058823529	0.00115194448374001	0.0117078669834393	1	1	0.53231329037209	0.969996934992558	0.0994105566966596
down	FN1; PDGFA; APP; SERPINE1; THBS1; VEGFC; TGFB2;	GO:0002576~platelet degranulation	7	124	5.64516129032258	0.00116082099859893	0.0117543874450722	1	1	0.533977659355509	0.969996934992558	0.0998055581939644
down	CSF2; SERPINE1; VIM; CSF3; TNFSF4; AXL; IL24; PDCD1LG2;	GO:0071222~cellular response to lipopolysaccharide	8	163	4.9079754601227	0.00124783351432922	0.0123985860069275	1	1	0.548098259698838	0.969996934992558	0.105275396359004
down	ADAMTS3; TBX3; FOSL1; EDNRA; PCGF2; NOTCH1; TWIST1; FUT8; TANC2;	GO:0001701~in utero embryonic development	9	203	4.43349753694581	0.00125185175610631	0.0123985860069275	1	1	0.548771362824784	0.969996934992558	0.105275396359004
down	WNT7A; SHH; KIF26B; FEZ1;	GO:0030010~establishment of cell polarity	4	35	11.4285714285714	0.0012713498331447	0.0123985860069275	1	1	0.551765827584799	0.969996934992558	0.105275396359004
down	TBX3; FOSL1; TGFB2; PROX1;	GO:0045787~positive regulation of cell cycle	4	35	11.4285714285714	0.0012713498331447	0.0123985860069275	1	1	0.551765827584799	0.969996934992558	0.105275396359004
down	NOTCH1; TGFB2; ROBO1;	GO:0003184~pulmonary valve morphogenesis	3	15	20	0.00127432431161179	0.0123985860069275	1	1	0.552208996646579	0.969996934992558	0.105275396359004
down	FGF5; DNER; METRN;	GO:0010001~glial cell differentiation	3	15	20	0.00127432431161179	0.0123985860069275	1	1	0.552208996646579	0.969996934992558	0.105275396359004
down	SNAI2; CD44; TWIST1;	GO:0043518~negative regulation of DNA damage response, signal transduction by p53 class mediator	3	15	20	0.00127432431161179	0.0123985860069275	1	1	0.552208996646579	0.969996934992558	0.105275396359004
down	NTRK1; GDNF; SOX4;	GO:0048485~sympathetic nervous system development	3	15	20	0.00127432431161179	0.0123985860069275	1	1	0.552208996646579	0.969996934992558	0.105275396359004
down	LHX1; FOXL2; TGFB2;	GO:0060065~uterus development	3	15	20	0.00127432431161179	0.0123985860069275	1	1	0.552208996646579	0.969996934992558	0.105275396359004
down	THBS1; NOTCH1; CARD10;	GO:0090051~negative regulation of cell migration involved in sprouting angiogenesis	3	15	20	0.00127432431161179	0.0123985860069275	1	1	0.552208996646579	0.969996934992558	0.105275396359004
down	CSF3; LIF; CD44; IL11; KITLG; CNTN1;	GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation	6	92	6.52173913043478	0.0012928473302698	0.0125342007126157	1	1	0.555048781108062	0.969996934992558	0.106426889915242
up	JCHAIN; IGKV1-5; IGKV3-20; IGKV3-15; IGLV1-47; IGLV2-14; IGLV2-23; IGLV3-1; IGLV3-25; IGHV3-23; IGKC; IGHA2; APOB; IGKV3-11; ATP1B1; IGKV4-1; CEACAM5; THBD; CD48; IGLC2; IGLC3; PSG1; SELE; SDC4; CEACAM3; CEACAM6; ATP1B3; CXADR; IGLV3-21; AIMP1; GRB7; ANGPT1; FCAMR; FOXJ1; SIRPG; CD84;	GO:0050900~leukocyte migration	36	193	18.6528497409326	0.00132994986353585	0.225254100961091	1	1	0.999999999678419	0.999999999678419	1
down	FN1; L1CAM; MAP1B; TNFRSF12A;	GO:0045773~positive regulation of axon extension	4	36	11.1111111111111	0.00139914046608802	0.0131720271454072	1	1	0.570849310163913	0.969996934992558	0.111842622845018
down	GJC1; GRIK2; ANO4; ATP13A5; ANO1; TMC7; NALCN; SFXN5; TTYH3;	GO:0034220~ion transmembrane transport	9	208	4.32692307692308	0.00147021485684085	0.0133985580620096	1	1	0.581294905513344	0.969996934992558	0.113766078634215
down	TERT; DOCK7; ADAMTS1;	GO:1904754~positive regulation of vascular associated smooth muscle cell migration	3	16	18.75	0.00149964233992583	0.0136213360709542	1	1	0.585716702950341	0.969996934992558	0.1156576687864
down	PDGFA; NTRK1; APP; ALOX15; CD44; NOTCH1; NODAL; CCL26; NTRK2;	GO:0070374~positive regulation of ERK1 and ERK2 cascade	9	209	4.30622009569378	0.00151735272085662	0.0137365640358345	1	1	0.588457850407134	0.969996934992558	0.116636060166484
down	ANO4; ANO1; SLC26A6; TTYH3;	GO:0006821~chloride transport	4	37	10.8108108108108	0.0015356208808569	0.0138104851587591	1	1	0.590948124249044	0.969996934992558	0.117263718474523
down	SNCB; STON2; SYT1; NLGN2;	GO:0048488~synaptic vesicle endocytosis	4	37	10.8108108108108	0.0015356208808569	0.0138104851587591	1	1	0.590948124249044	0.969996934992558	0.117263718474523
up	APOA1; APOC3; APOB; APOA4; LPL; GPIHBP1;	GO:0034371~chylomicron remodeling	6	9	66.6666666666667	0.0015499233909726	0.253010590032693	1	1	0.999999999678419	0.999999999678419	1
down	THBS1; INHBA; NOTCH1; MAPK12; TGFB2; PKD2; BTG4;	GO:0007050~cell cycle arrest	7	131	5.34351145038168	0.00156742379625541	0.0140502841277452	1	1	0.594846359659469	0.969996934992558	0.119299832229139
up	KRT33A; KRT37; KRT38; KRT6A; KRT6B; KRT16; KRT3; JUP; DSP; KRT15; KRT4; DSG3; KRT6C; DSG1; DSC2; TGM3; PKP1; KRT32; DSC3; KRT31; LCE3C; LCE3E; LCE3A; KRT79; KRT40; KRT80; KRT77; HRNR; KRT78; KRT35; SPRR4; CNFN; KRTAP3-2; PKP3;	GO:0031424~keratinization	34	181	18.7845303867403	0.00160448438901117	0.253010590032693	1	1	0.999999999678419	0.999999999678419	1
down	DISP2; EVC; SHH; DZIP1; DISP3;	GO:0007224~smoothened signaling pathway	5	65	7.69230769230769	0.00165355302639669	0.0147739018763678	1	1	0.604044092243017	0.969996934992558	0.125444012320006
down	SLC26A4; ANO4; ANO1; SLC26A6; TTYH3; SLC12A4;	GO:1902476~chloride transmembrane transport	6	97	6.18556701030928	0.00166908549974965	0.0148641034407672	1	1	0.605878036409121	0.969996934992558	0.126209906546899
down	WDR66; DNAH5; WDR78; ZBBX;	GO:0003341~cilium movement	4	38	10.5263157894737	0.00168109426844221	0.0149224406815617	1	1	0.606875030907637	0.969996934992558	0.126705243365444
down	COL12A1; COL7A1; MATN3;	GO:0003429~growth plate cartilage chondrocyte morphogenesis	3	17	17.6470588235294	0.00174841824858107	0.0154199209407118	1	1	0.613694805251957	0.969996934992558	0.130929308225223
down	PLAU; SERPINE1; PCSK9;	GO:0010469~regulation of signaling receptor activity	3	17	17.6470588235294	0.00174841824858107	0.0154199209407118	1	1	0.613694805251957	0.969996934992558	0.130929308225223
down	NTRK1; IGF1R; GRK5; EPHB4; PRKD1; NTRK2; MEX3B; NEK6;	GO:0046777~protein autophosphorylation	8	173	4.6242774566474	0.00178690012455573	0.0157086332493099	1	1	0.617651419847911	0.969996934992558	0.133380741211565
down	PRRX1; TGFB2; SHH; HOXC10;	GO:0030326~embryonic limb morphogenesis	4	39	10.2564102564103	0.00183586224581644	0.0160359341216043	1	1	0.622357301331775	0.969996934992558	0.13615982658793
down	THBS1; VEGFC; PRKD1; AMOTL1;	GO:0043536~positive regulation of blood vessel endothelial cell migration	4	39	10.2564102564103	0.00183586224581644	0.0160359341216043	1	1	0.622357301331775	0.969996934992558	0.13615982658793
up	CD5L; IGKV1-5; IGKV3-20; IGKV3-15; IGLV1-47; IGLV2-14; IGLV2-23; IGLV3-1; IGLV3-25; IGHV3-23; IGKC; IGHG2; IGHG3; IGHG4; C1QA; C1QB; C1QC; C9; IGKV3-11; IGKV4-1; IGLC2; IGLC3; CD19; IGLV3-21;	GO:0030449~regulation of complement activation	24	113	21.2389380530973	0.00187154334969641	0.276598680889637	1	1	0.999999999678419	0.999999999678419	1
up	ALOX15B; MT1A; MT1G; MT1H; MT1X; PTK6; MT1M; PNPT1;	GO:0045926~negative regulation of growth	8	18	44.4444444444444	0.00189160719362991	0.276598680889637	1	1	0.999999999678419	0.999999999678419	1
up	A2ML1; CSTA; CSTB; SPINK8; PZP; SERPINB3; PEBP1; SERPINB1; RARRES1; SERPINB8; SPINK7; ITIH3; CST6; SPINK9; CST9; CARD17; ITIH5; NLRP7; CSTL1; FETUB; SERPINB13; UCHL5; SERPINI2; SERPINB4; SERPINA11; SERPINB2; SERPINB12; SERPINB5; SERPINB11;	GO:0010951~negative regulation of endopeptidase activity	29	148	19.5945945945946	0.00197580283665377	0.276598680889637	1	1	0.999999999678419	0.999999999678419	1
down	TGFB1I1; TBX1; COL4A1; CASP6; SIX1;	GO:0030855~epithelial cell differentiation	5	68	7.35294117647059	0.00199198182540816	0.0171346351014033	1	1	0.638139725616645	0.969996934992558	0.145488808220491
up	UGT1A9; UGT1A1; UGT1A7; UGT1A10; UGT1A8;	GO:0051552~flavone metabolic process	5	6	83.3333333333333	0.00199601059902865	0.276598680889637	1	1	0.999999999678419	0.999999999678419	1
down	NEFL; VIM; SHH;	GO:0045109~intermediate filament organization	3	18	16.6666666666667	0.00202148789280721	0.0171346351014033	1	1	0.640915560591763	0.969996934992558	0.145488808220491
down	ITGA2; ADRA1B; ADRA1D;	GO:0045987~positive regulation of smooth muscle contraction	3	18	16.6666666666667	0.00202148789280721	0.0171346351014033	1	1	0.640915560591763	0.969996934992558	0.145488808220491
down	GDF11; FAT1; TENM3;	GO:0048593~camera-type eye morphogenesis	3	18	16.6666666666667	0.00202148789280721	0.0171346351014033	1	1	0.640915560591763	0.969996934992558	0.145488808220491
down	SYT1; GRIK2; CLSTN1;	GO:0050806~positive regulation of synaptic transmission	3	18	16.6666666666667	0.00202148789280721	0.0171346351014033	1	1	0.640915560591763	0.969996934992558	0.145488808220491
down	WNT7A; SHANK3; CTNND2;	GO:0060997~dendritic spine morphogenesis	3	18	16.6666666666667	0.00202148789280721	0.0171346351014033	1	1	0.640915560591763	0.969996934992558	0.145488808220491
down	CLSTN1; MELTF; BCAR1; SPOCK1; PAPPA2;	GO:0001558~regulation of cell growth	5	69	7.2463768115942	0.00211526386139926	0.0171346351014033	1	1	0.650749436510058	0.969996934992558	0.145488808220491
down	CSF2; LIF; ISL1; IL24; IL31RA;	GO:0042531~positive regulation of tyrosine phosphorylation of STAT protein	5	69	7.2463768115942	0.00211526386139926	0.0171346351014033	1	1	0.650749436510058	0.969996934992558	0.145488808220491
down	THBS1; VIM; ITGA2; SOX4; LARP6;	GO:0045727~positive regulation of translation	5	70	7.14285714285714	0.00224401490133319	0.0178866960356995	1	1	0.661075989083922	0.969996934992558	0.151874497112751
down	DLX2; DLX1; OSR1;	GO:0009790~embryo development	3	19	15.7894736842105	0.00231964601472423	0.0181716682070374	1	1	0.666402119638465	0.969996934992558	0.154294172894498
down	ISL1; SOX4; SHH;	GO:0021522~spinal cord motor neuron differentiation	3	19	15.7894736842105	0.00231964601472423	0.0181716682070374	1	1	0.666402119638465	0.969996934992558	0.154294172894498
down	MDK; NOTCH1; SFRP1;	GO:0030279~negative regulation of ossification	3	19	15.7894736842105	0.00231964601472423	0.0181716682070374	1	1	0.666402119638465	0.969996934992558	0.154294172894498
down	BMPR1B; RUNX2; LOXL2;	GO:0032332~positive regulation of chondrocyte differentiation	3	19	15.7894736842105	0.00231964601472423	0.0181716682070374	1	1	0.666402119638465	0.969996934992558	0.154294172894498
down	SERPINE2; RET; ISL1;	GO:0060384~innervation	3	19	15.7894736842105	0.00231964601472423	0.0181716682070374	1	1	0.666402119638465	0.969996934992558	0.154294172894498
down	TERT; HMGA2; TWIST1;	GO:2000773~negative regulation of cellular senescence	3	19	15.7894736842105	0.00231964601472423	0.0181716682070374	1	1	0.666402119638465	0.969996934992558	0.154294172894498
up	CCL21; CCL22; WNT9B; EREG; SIGLEC6; CXCL13; CXCL14; POMC; C1QA; PGR; S100A9; EDN3; NTF3; FGFR3; XCL1; FASLG; CCR5; EFNA3; AFDN; CCL18; CX3CL1; CCL8; PCDH1; AIMP1; IL18; GPNMB; LILRB2; CCL17; TFAP2C; FGF14; FCRL2; TBX5; IL26; STAB1; IL36G; SIRPG; ADRB2; ADRA2C; ADRA2A; FGFBP1;	GO:0007267~cell-cell signaling	40	230	17.3913043478261	0.00232156325214872	0.312250257414002	1	1	0.999999999678419	0.999999999678419	1
down	KRT75; KRT8; KRTAP2-3; CDH3; DSG2; LCE1C; LCE1E; LCE1B;	GO:0031424~keratinization	8	181	4.41988950276243	0.0023382890054956	0.0182653775457856	1	1	0.667988170588309	0.969996934992558	0.155089851351199
down	FGD1; NTRK2; FGD6; BVES; AJUBA;	GO:0043087~regulation of GTPase activity	5	71	7.04225352112676	0.00237837516260775	0.0184729479959363	1	1	0.670701795855385	0.969996934992558	0.156852315345062
down	CDH11; GRIK2; NLGN2; NTNG1; GRIN3B;	GO:0050804~modulation of chemical synaptic transmission	5	71	7.04225352112676	0.00237837516260775	0.0184729479959363	1	1	0.670701795855385	0.969996934992558	0.156852315345062
down	TBX1; SLC26A4; SNAI2; COL2A1; COL11A1; SIX1; PDZD7;	GO:0007605~sensory perception of sound	7	143	4.89510489510489	0.00251338944183421	0.019466308028257	1	1	0.68045965241986	0.969996934992558	0.165286855466922
down	AXL; NOTCH1; PGF; PTPRU;	GO:0031100~animal organ regeneration	4	43	9.30232558139535	0.00255384333717523	0.0197237505193138	1	1	0.68317450633496	0.969996934992558	0.167472778948076
down	CDH3; CAV1; SOX4; PTK7; SFRP1; SMURF2; LYPD6;	GO:0090263~positive regulation of canonical Wnt signaling pathway	7	144	4.86111111111111	0.0026085055140932	0.0200770327506373	1	1	0.686925599827325	0.969996934992558	0.170472469953841
down	CSF2; PKD2; NODAL;	GO:0001892~embryonic placenta development	3	20	15	0.00264364732634581	0.0200770327506373	1	1	0.689842568582573	0.969996934992558	0.170472469953841
down	HOXC11; LAMC1; NOTCH1;	GO:0007492~endoderm development	3	20	15	0.00264364732634581	0.0200770327506373	1	1	0.689842568582573	0.969996934992558	0.170472469953841
down	NTRK1; BCAR1; NTRK2;	GO:0048011~neurotrophin TRK receptor signaling pathway	3	20	15	0.00264364732634581	0.0200770327506373	1	1	0.689842568582573	0.969996934992558	0.170472469953841
down	APP; GRIK2; SYNPO;	GO:0048169~regulation of long-term neuronal synaptic plasticity	3	20	15	0.00264364732634581	0.0200770327506373	1	1	0.689842568582573	0.969996934992558	0.170472469953841
down	WNT7A; ARHGAP22; NRCAM;	GO:0099175~regulation of postsynapse organization	3	20	15	0.00264364732634581	0.0200770327506373	1	1	0.689842568582573	0.969996934992558	0.170472469953841
down	LCAT; APP; PCSK9; DISP3; LIMA1;	GO:0008203~cholesterol metabolic process	5	73	6.84931506849315	0.00266448548056442	0.0201792335287067	1	1	0.690835469763812	0.969996934992558	0.171340248538708
down	RBFOX2; APP; NEFL; NLGN2;	GO:0050885~neuromuscular process controlling balance	4	44	9.09090909090909	0.0027595362025421	0.0208413590545583	1	1	0.698091286088255	0.969996934992558	0.176962303112874
up	HP; HPR; JCHAIN; IGKV1-5; IGKV3-20; IGKV3-15; IGLV1-47; IGLV2-14; IGLV2-23; IGLV3-1; IGLV3-25; IGHV3-23; IGKC; IGHA2; APOA1; APOB; IGKV3-11; IGKV4-1; ADRB2; IGLC2; IGLC3; FOLR2; FCGR2B; HBA1; IGLV3-21; COLEC12; CLEC9A; FCGR1B; STAB1; CD207;	GO:0006898~receptor-mediated endocytosis	30	160	18.75	0.00297222410948916	0.377555023685943	1	1	0.999999999678419	0.999999999678419	1
down	NTRK1; SERPINE1; NTRK2; PROX1; HS3ST2;	GO:0007623~circadian rhythm	5	75	6.66666666666667	0.00297472062489468	0.0212076774511469	1	1	0.708361872367244	0.969996934992558	0.180072683149187
down	SNAI2; EDNRA; FOXC2;	GO:0014032~neural crest cell development	3	21	14.2857142857143	0.0029942075699132	0.0212076774511469	1	1	0.709493797732562	0.969996934992558	0.180072683149187
down	FSTL3; MDK; DKK3;	GO:0030325~adrenal gland development	3	21	14.2857142857143	0.0029942075699132	0.0212076774511469	1	1	0.709493797732562	0.969996934992558	0.180072683149187
down	SHH; SFRP1; FOXA2;	GO:0071542~dopaminergic neuron differentiation	3	21	14.2857142857143	0.0029942075699132	0.0212076774511469	1	1	0.709493797732562	0.969996934992558	0.180072683149187
down	TERT; KCNK2; TWIST1; SFRP1; SCN2A; TIGAR;	GO:0071456~cellular response to hypoxia	6	111	5.40540540540541	0.00316748165573266	0.0223769892681475	1	1	0.715850854195582	0.969996934992558	0.190001215720017
up	LGALS3; CCL11; CX3CL1; CCL18; XCL1; XCL2; CCL8; CCL2;	GO:0048245~eosinophil chemotaxis	8	20	40	0.00318015399804561	0.381777893959694	1	1	0.999999999678419	0.999999999678419	1
up	IRF6; EREG; KLK8; FST; PPARD; SDR16C5;	GO:0043616~keratinocyte proliferation	6	11	54.5454545454545	0.00325592343416314	0.381777893959694	1	1	0.999999999678419	0.999999999678419	1
up	JUP; DSP; DSC2; DLG1; RYR2; CTNNA3;	GO:0098911~regulation of ventricular cardiac muscle cell action potential	6	11	54.5454545454545	0.00325592343416314	0.381777893959694	1	1	0.999999999678419	0.999999999678419	1
down	TBX3; ITGA2; CAV1;	GO:0030879~mammary gland development	3	22	13.6363636363636	0.00337200455538333	0.0234581690952113	1	1	0.723633272211201	0.969996934992558	0.199181426654224
down	LOXL1; PKD2; ROBO1;	GO:0035904~aorta development	3	22	13.6363636363636	0.00337200455538333	0.0234581690952113	1	1	0.723633272211201	0.969996934992558	0.199181426654224
down	APOD; MDK; NOTCH1;	GO:0042246~tissue regeneration	3	22	13.6363636363636	0.00337200455538333	0.0234581690952113	1	1	0.723633272211201	0.969996934992558	0.199181426654224
down	FAT1; VANGL2; MTCL1;	GO:0045197~establishment or maintenance of epithelial cell apical/basal polarity	3	22	13.6363636363636	0.00337200455538333	0.0234581690952113	1	1	0.723633272211201	0.969996934992558	0.199181426654224
down	NOTCH1; MMP14; SHH;	GO:0048754~branching morphogenesis of an epithelial tube	3	22	13.6363636363636	0.00337200455538333	0.0234581690952113	1	1	0.723633272211201	0.969996934992558	0.199181426654224
down	MDK; PROX1; DISP3;	GO:2000179~positive regulation of neural precursor cell proliferation	3	22	13.6363636363636	0.00337200455538333	0.0234581690952113	1	1	0.723633272211201	0.969996934992558	0.199181426654224
down	APP; RAG1; HRH1; SYNPO;	GO:0008542~visual learning	4	47	8.51063829787234	0.003444094159609	0.0237182706105063	1	1	0.726590450793702	0.969996934992558	0.201389927696275
down	LIF; TGFB2; TENM3; TENM2;	GO:0048666~neuron development	4	47	8.51063829787234	0.003444094159609	0.0237182706105063	1	1	0.726590450793702	0.969996934992558	0.201389927696275
down	NOTCH1; DOCK7; FOXC2; HOXC10;	GO:0120163~negative regulation of cold-induced thermogenesis	4	47	8.51063829787234	0.003444094159609	0.0237182706105063	1	1	0.726590450793702	0.969996934992558	0.201389927696275
down	TGFB2; TEAD2; TWIST1; DLC1; VANGL2;	GO:0001843~neural tube closure	5	78	6.41025641025641	0.0034877719145493	0.0239587146089894	1	1	0.728120920410961	0.969996934992558	0.203431518344459
down	FLRT2; RBFOX2; FRS3; FGF5; FLRT3;	GO:0008543~fibroblast growth factor receptor signaling pathway	5	79	6.32911392405063	0.00367207125032809	0.0250986069959925	1	1	0.734618374246195	0.969996934992558	0.213110252901877
down	INHBA; NODAL; TGFB2; GDF11;	GO:0010862~positive regulation of pathway-restricted SMAD protein phosphorylation	4	48	8.33333333333333	0.00369570895097004	0.0251971777355414	1	1	0.735475677182788	0.969996934992558	0.213947209121692
down	KCNU1; NALCN; KCNA7; SCN2A; KCNF1; KCNJ12;	GO:0034765~regulation of ion transmembrane transport	6	115	5.21739130434783	0.00373789542747505	0.0253763510303077	1	1	0.737222431916097	0.969996934992558	0.215468555153645
down	NOTCH1; VEGFC; SHH;	GO:0002052~positive regulation of neuroblast proliferation	3	23	13.0434782608696	0.00377767917678684	0.0253763510303077	1	1	0.739013408288225	0.969996934992558	0.215468555153645
down	GRIN3B; APP; GRIK2;	GO:0035235~ionotropic glutamate receptor signaling pathway	3	23	13.0434782608696	0.00377767917678684	0.0253763510303077	1	1	0.739013408288225	0.969996934992558	0.215468555153645
down	TBX1; PRRX1; FOXC2;	GO:0048844~artery morphogenesis	3	23	13.0434782608696	0.00377767917678684	0.0253763510303077	1	1	0.739013408288225	0.969996934992558	0.215468555153645
down	NTRK1; NLGN2; SHANK3;	GO:0051968~positive regulation of synaptic transmission, glutamatergic	3	23	13.0434782608696	0.00377767917678684	0.0253763510303077	1	1	0.739013408288225	0.969996934992558	0.215468555153645
down	NOTCH1; PRRX1; PROX1;	GO:0097150~neuronal stem cell population maintenance	3	23	13.0434782608696	0.00377767917678684	0.0253763510303077	1	1	0.739013408288225	0.969996934992558	0.215468555153645
up	CCL21; CXCL13; OXSR1; S100A7; CCR2; XCL1; XCL2;	GO:0010820~positive regulation of T cell chemotaxis	7	16	43.75	0.00387506031142903	0.439646395135921	1	1	0.999999999678419	0.999999999678419	1
down	NUAK1; RET; LAMA1; LAMA3;	GO:0030155~regulation of cell adhesion	4	49	8.16326530612245	0.00395949719400512	0.0256522875080806	1	1	0.745655439866974	0.969996934992558	0.217811509588225
up	ARPC3; IGKV1-5; IGKV3-20; IGKV3-15; IGLV1-47; IGLV2-14; IGLV2-23; IGLV3-1; IGLV3-25; IGHV3-23; IGKC; IGHG2; IGHG3; IGHG4; IGKV3-11; IGKV4-1; CD3G; IGLC2; IGLC3; FCGR2A; NCK1; FCGR2B; NCKAP1L; IGLV3-21; BRK1; BAIAP2;	GO:0038096~Fc-gamma receptor signaling pathway involved in phagocytosis	26	135	19.2592592592593	0.00398498292673899	0.439646395135921	1	1	0.999999999678419	0.999999999678419	1
up	PLA2G4B; PLA2G2A; PLA2G5; PLA2G4A; PLA2G4E; PLA2G4F; PLA2G4D; PLA2G12A;	GO:0036150~phosphatidylserine acyl-chain remodeling	8	21	38.0952380952381	0.00403786323982258	0.439646395135921	1	1	0.999999999678419	0.999999999678419	1
down	MAPK11; SFRP1; HAS2; ADAMTS7; CCL26;	GO:0071347~cellular response to interleukin-1	5	81	6.17283950617284	0.00406143459710728	0.026250501627639	1	1	0.749734899495516	0.969996934992558	0.22289089755302
down	PDGFA; FGD1; FSCN1; FGD6; DLC1; MICAL3; AMOTL1;	GO:0030036~actin cytoskeleton organization	7	157	4.45859872611465	0.00411338726576738	0.026523586756151	1	1	0.751859031922791	0.969996934992558	0.225209641410407
down	ONECUT2; SOX4; FOXA2;	GO:0031018~endocrine pancreas development	3	24	12.5	0.0042118364066166	0.0269133292574501	1	1	0.755157420656694	0.969996934992558	0.228518913635424
down	WDR54; NTRK1; NTRK2;	GO:0043408~regulation of MAPK cascade	3	24	12.5	0.0042118364066166	0.0269133292574501	1	1	0.755157420656694	0.969996934992558	0.228518913635424
down	FSTL3; FBN1; SFRP1;	GO:0045671~negative regulation of osteoclast differentiation	3	24	12.5	0.0042118364066166	0.0269133292574501	1	1	0.755157420656694	0.969996934992558	0.228518913635424
down	NEFL; CRMP1; MAP6; DOCK7; MARK1; MAP1B;	GO:0000226~microtubule cytoskeleton organization	6	118	5.08474576271187	0.00421320589692342	0.0269133292574501	1	1	0.755157420656694	0.969996934992558	0.228518913635424
down	PLOD2; LOX; FBXO2; FBXL2; LOXL2;	GO:0006464~cellular protein modification process	5	82	6.09756097560976	0.00426677788527985	0.0271920063831121	1	1	0.757434879544389	0.969996934992558	0.230885138690755
up	CCL22; DEFB4A; CXCL14; RNASE2; CCL2; FPR3; CCL11; NCKAP1L; CCL18; DEFB1; CX3CL1; CCL8; AIMP1; PLD1; RALBP1; ECSCR; CMTM8; CCL17; RARRES2; CXCR3; CCR8; CCR2; ACKR2; CCR5;	GO:0006935~chemotaxis	24	122	19.672131147541	0.00438704468000761	0.466557100504065	1	1	0.999999999678419	0.999999999678419	1
down	KCNK2; ITGA3; HRH1; SCN2A; SHANK3;	GO:0007613~memory	5	83	6.02409638554217	0.00447941438391863	0.0284807416875199	1	1	0.765945383808933	0.969996934992558	0.241827686485928
down	AGRN; HSPG2; GPC6;	GO:0006027~glycosaminoglycan catabolic process	3	25	12	0.00467504626960613	0.02951865242749	1	1	0.772594215265607	0.969996934992558	0.250640503082479
down	SEMA4F; SEMA6D; SEMA3C;	GO:0048843~negative regulation of axon extension involved in axon guidance	3	25	12	0.00467504626960613	0.02951865242749	1	1	0.772594215265607	0.969996934992558	0.250640503082479
down	FLRT3; NTNG1; GPC6;	GO:0099560~synaptic membrane adhesion	3	25	12	0.00467504626960613	0.02951865242749	1	1	0.772594215265607	0.969996934992558	0.250640503082479
up	DKK1; C1QA; C1QB; C1QC; CX3CL1;	GO:0098883~synapse pruning	5	8	62.5	0.00474438570100344	0.493092632061107	1	1	0.999999999678419	0.999999999678419	1
down	SH3PXD2B; PXN; SFRP1; FHOD1;	GO:0051496~positive regulation of stress fiber assembly	4	52	7.69230769230769	0.0048265808901139	0.0300382907605116	1	1	0.778299341612302	0.969996934992558	0.255052710364956
down	RBFOX2; NUAK1; PLAU; MELTF; PKD2; SHH; TGFB2;	GO:0042127~regulation of cell population proliferation	7	163	4.29447852760736	0.00499633858715864	0.0300382907605116	1	1	0.784425158183907	0.969996934992558	0.255052710364956
up	GCAT; DDC; GGT5; PTS; PM20D1; KYAT3; PHGDH;	GO:0006520~cellular amino acid metabolic process	7	17	41.1764705882353	0.005036532009566	0.511823575105451	1	1	0.999999999678419	0.999999999678419	1
down	EFNB1; CAV1; EFNB3; PDCD1LG2;	GO:0031295~T cell costimulation	4	53	7.54716981132075	0.00514172089334108	0.0304501889429427	1	1	0.790606969591869	0.969996934992558	0.258550104696113
down	CAV1; SOX4; SH3RF2; RASD2;	GO:0031397~negative regulation of protein ubiquitination	4	53	7.54716981132075	0.00514172089334108	0.0304501889429427	1	1	0.790606969591869	0.969996934992558	0.258550104696113
down	PTHLH; FOSL1; ITGA2; PGF; COL16A1;	GO:0007565~female pregnancy	5	86	5.81395348837209	0.00516246491861838	0.0304501889429427	1	1	0.790606969591869	0.969996934992558	0.258550104696113
down	RGS3; CAV1; SPRED3;	GO:0000188~inactivation of MAPK activity	3	26	11.5384615384615	0.00516784479499832	0.0304501889429427	1	1	0.790680253634743	0.969996934992558	0.258550104696113
down	APP; ITGA3; VANGL2;	GO:0030111~regulation of Wnt signaling pathway	3	26	11.5384615384615	0.00516784479499832	0.0304501889429427	1	1	0.790680253634743	0.969996934992558	0.258550104696113
down	DSCAM; APP; THBS1;	GO:0042327~positive regulation of phosphorylation	3	26	11.5384615384615	0.00516784479499832	0.0304501889429427	1	1	0.790680253634743	0.969996934992558	0.258550104696113
down	WNT7A; NLGN2; SHANK3;	GO:2000463~positive regulation of excitatory postsynaptic potential	3	26	11.5384615384615	0.00516784479499832	0.0304501889429427	1	1	0.790680253634743	0.969996934992558	0.258550104696113
down	SLIT3; SERPINE2; INHBA; TGFB2; SFRP1; DCBLD2;	GO:0030308~negative regulation of cell growth	6	124	4.83870967741935	0.00529567418666366	0.0311362865082547	1	1	0.795605680780334	0.969996934992558	0.264375703928865
down	APP; CPS1; PKD2; SLC26A6;	GO:0071320~cellular response to cAMP	4	54	7.40740740740741	0.00547034256514811	0.032094241573208	1	1	0.802366321536806	0.969996934992558	0.272509623321022
down	THBS1; POSTN; SFRP1; HAS2; ADAMTS7; CCL26;	GO:0071356~cellular response to tumor necrosis factor	6	125	4.8	0.00549414713980201	0.0321648785443655	1	1	0.802366321536806	0.969996934992558	0.273109396160606
down	ITGB4; MMP14; FSCN1;	GO:0048870~cell motility	3	27	11.1111111111111	0.00569073494965433	0.033244592633237	1	1	0.806077948058201	0.969996934992558	0.282277161629737
down	TBX1; MAPK12; EVC; TWIST1; BVES;	GO:0007517~muscle organ development	5	89	5.61797752808989	0.00591610172669998	0.034487467208524	1	1	0.810098876789711	0.969996934992558	0.292830309663291
down	SHANK3; ADRA1D; ADRA1B;	GO:0007610~behavior	3	28	10.7142857142857	0.00624418755041845	0.0350546381167229	1	1	0.815389572489068	0.969996934992558	0.297646112217757
down	ISL1; CCBE1; NODAL;	GO:0010575~positive regulation of vascular endothelial growth factor production	3	28	10.7142857142857	0.00624418755041845	0.0350546381167229	1	1	0.815389572489068	0.969996934992558	0.297646112217757
down	TERT; LOX; POLM;	GO:0071897~DNA biosynthetic process	3	28	10.7142857142857	0.00624418755041845	0.0350546381167229	1	1	0.815389572489068	0.969996934992558	0.297646112217757
up	FABP12; APOC3; APOB; LPL; FABP1; FABP2; FABP5; MGLL;	GO:0019433~triglyceride catabolic process	8	23	34.7826086956522	0.00627636411034027	0.602737462600177	1	1	0.999999999678419	0.999999999678419	1
up	CD1A; CD1C; CD1E; CD1B;	GO:0048006~antigen processing and presentation, endogenous lipid antigen via MHC class Ib	4	5	80	0.00644589322727018	0.602737462600177	1	1	0.999999999678419	0.999999999678419	1
down	LCAT; PLPP4; PCSK9; PLPPR5;	GO:0006644~phospholipid metabolic process	4	57	7.01754385964912	0.00653956219406837	0.036637629177424	1	1	0.820243421754533	0.969996934992558	0.311087161967702
down	COL4A1; APOD; SYT1; PTPRG; HSPG2; DLX2; PROX1; NODAL;	GO:0007420~brain development	8	217	3.68663594470046	0.00663910418027869	0.0371192450488383	1	1	0.822311978077011	0.969996934992558	0.315176523587454
down	TNFSF4; AXL; PDCD1LG2;	GO:0032689~negative regulation of interferon-gamma production	3	29	10.3448275862069	0.00682864215723145	0.0377925256232202	1	1	0.825563987295523	0.969996934992558	0.320893294781304
down	RAG1; SHH; FZD8;	GO:0033077~T cell differentiation in thymus	3	29	10.3448275862069	0.00682864215723145	0.0377925256232202	1	1	0.825563987295523	0.969996934992558	0.320893294781304
down	NTRK1; KITLG; NOTCH1;	GO:0046579~positive regulation of Ras protein signal transduction	3	29	10.3448275862069	0.00682864215723145	0.0377925256232202	1	1	0.825563987295523	0.969996934992558	0.320893294781304
down	NOTCH1; NTRK2; SHH;	GO:0048709~oligodendrocyte differentiation	3	29	10.3448275862069	0.00682864215723145	0.0377925256232202	1	1	0.825563987295523	0.969996934992558	0.320893294781304
down	WNT7A; APP; GPC6;	GO:1905606~regulation of presynapse assembly	3	29	10.3448275862069	0.00682864215723145	0.0377925256232202	1	1	0.825563987295523	0.969996934992558	0.320893294781304
up	CCL21; RAMP3; EGFR; PLA2G2A; FGFR3; FSHR; S100A7; FLT4; CHRNA7; PLA2G5; CASR; CX3CL1; SLAMF1; GPNMB; ANGPT1; SYT14P1; TNFAIP8L3; FFAR4; SCIMP; NPNT; SLC30A10; CCL19; GAREM1; IL26; GPR55; CCL8; CCL11; CCL17; HMGB1P1; XCL1; CCL22; CCL14; CCL2; XCL2; CCL18;	GO:0070374~positive regulation of ERK1 and ERK2 cascade	35	209	16.7464114832536	0.0069221842833066	0.633102974551221	1	1	0.999999999678419	0.999999999678419	1
down	COL2A1; SHH; DNER; NRCAM; TAGLN3; TBX3;	GO:0007417~central nervous system development	6	133	4.51127819548872	0.0072826409935518	0.0402237181340821	1	1	0.832665313548191	0.969996934992558	0.341536354809522
down	GDF11; APP; ISL1; DISP3;	GO:0045665~negative regulation of neuron differentiation	4	59	6.77966101694915	0.00732422044614578	0.0403718118946826	1	1	0.833934279064132	0.969996934992558	0.34279380701712
down	TBX1; GDF11; FOXC2;	GO:0007498~mesoderm development	3	30	10	0.0074445079472496	0.0403863703644347	1	1	0.835229681361655	0.969996934992558	0.342917421812604
down	TERT; SERPINE1; IL11;	GO:2000352~negative regulation of endothelial cell apoptotic process	3	30	10	0.0074445079472496	0.0403863703644347	1	1	0.835229681361655	0.969996934992558	0.342917421812604
up	PLA2G2A; BDKRB2; PLA2G4A; PLA2G4F; PLA2G12A; PLA2G3; ANXA1; PLA2G5;	GO:0050482~arachidonic acid secretion	8	24	33.3333333333333	0.00769746768046198	0.66416074910854	1	1	0.999999999678419	0.999999999678419	1
down	HRH1; ANO1; ADRA1D; ADRA1B;	GO:0007200~phospholipase C-activating G protein-coupled receptor signaling pathway	4	60	6.66666666666667	0.00773879276349199	0.0410832221658002	1	1	0.84069289974686	0.969996934992558	0.348834334398543
down	PDGFA; KITLG; AJUBA; ROBO1;	GO:0043406~positive regulation of MAP kinase activity	4	60	6.66666666666667	0.00773879276349199	0.0410832221658002	1	1	0.84069289974686	0.969996934992558	0.348834334398543
down	BMPR1B; RUNX2; PRKD1; FAM20C;	GO:0045669~positive regulation of osteoblast differentiation	4	60	6.66666666666667	0.00773879276349199	0.0410832221658002	1	1	0.84069289974686	0.969996934992558	0.348834334398543
down	SLC26A4; SLC9A3; SLC9A5; SLC26A6; SLC12A4;	GO:0006811~ion transport	5	96	5.20833333333333	0.0079694222767539	0.0422255823733433	1	1	0.844758761335914	0.969996934992558	0.358534023021638
up	CCL2; LGALS3; EDN2; EDNRB; CX3CL1; CXCL17;	GO:0048246~macrophage chemotaxis	6	14	42.8571428571429	0.00799563672797787	0.67490710241018	1	1	0.999999999678419	0.999999999678419	1
down	THBS1; NR2F2; CAV1;	GO:0001937~negative regulation of endothelial cell proliferation	3	31	9.67741935483871	0.00809216456976447	0.0427103821114596	1	1	0.846652774348902	0.969996934992558	0.362650418597425
down	CDK5R2; PKD2; PROX1;	GO:0045737~positive regulation of cyclin-dependent protein serine/threonine kinase activity	3	31	9.67741935483871	0.00809216456976447	0.0427103821114596	1	1	0.846652774348902	0.969996934992558	0.362650418597425
up	PLA2G2A; PLA2G5; PLA2G4A; PLA2G4E; PLA2G4F; PLA2G4D; PLA2G12A;	GO:0036149~phosphatidylinositol acyl-chain remodeling	7	19	36.8421052631579	0.00811718579325604	0.67490710241018	1	1	0.999999999678419	0.999999999678419	1
down	VIM; PTPRG; SPOCK1; CRMP1;	GO:0010977~negative regulation of neuron projection development	4	61	6.55737704918033	0.00816848885227728	0.0429474010040886	1	1	0.848228373381626	0.969996934992558	0.364662926947341
down	EFNB1; CD276; PDCD1LG2; TNFSF4;	GO:0042102~positive regulation of T cell proliferation	4	61	6.55737704918033	0.00816848885227728	0.0429474010040886	1	1	0.848228373381626	0.969996934992558	0.364662926947341
up	PIR; ALPI; PGA3; PGA5; PGC; PRSS3; AKR1C2; GKN1; CYP39A1;	GO:0007586~digestion	9	30	30	0.00839871947385296	0.684365720628149	1	1	0.999999999678419	0.999999999678419	1
down	APP; FOSL1; NTRK2; SHANK3;	GO:0007612~learning	4	62	6.45161290322581	0.00861352362245138	0.0452003331742458	1	1	0.854910431930045	0.969996934992558	0.383792392763099
down	NEFL; SOX4; PKD2;	GO:0021510~spinal cord development	3	32	9.375	0.00877196298306515	0.0457477937627332	1	1	0.858498944854196	0.969996934992558	0.388440836578526
down	SEMA4F; SEMA6D; SEMA3C;	GO:0071526~semaphorin-plexin signaling pathway	3	32	9.375	0.00877196298306515	0.0457477937627332	1	1	0.858498944854196	0.969996934992558	0.388440836578526
down	WNT7A; SOX4; SFRP1; VANGL2;	GO:0035019~somatic stem cell population maintenance	4	63	6.34920634920635	0.00907410684914112	0.0461126545084606	1	1	0.862269154635265	0.969996934992558	0.39153883981864
up	IL2RA; IL20RB; IL36A; IL1RN; IL36RN; IL1F10; IL36G; IL36B;	GO:0002437~inflammatory response to antigenic stimulus	8	25	32	0.00934723685285599	0.684365720628149	1	1	0.999999999678419	0.999999999678419	1
up	CYP2A6; CYP2C9; CYP4B1; CYP2C19; NUDT15; CYP2F1; CYP2C18; CYP2G1P;	GO:0042738~exogenous drug catabolic process	8	25	32	0.00934723685285599	0.684365720628149	1	1	0.999999999678419	0.999999999678419	1
down	SH3PXD2B; HOXC8; NKX3-2;	GO:0048705~skeletal system morphogenesis	3	33	9.09090909090909	0.00948422627297463	0.0480182863524308	1	1	0.870412807762376	0.969996934992558	0.407719406503923
down	TERT; MMP2; ADAMTS1;	GO:1904707~positive regulation of vascular smooth muscle cell proliferation	3	33	9.09090909090909	0.00948422627297463	0.0480182863524308	1	1	0.870412807762376	0.969996934992558	0.407719406503923
up	APOA1; IL10; ANGPT1; LILRB1;	GO:0002740~negative regulation of cytokine secretion involved in immune response	4	6	66.6666666666667	0.00995713756356253	0.684365720628149	1	1	0.999999999678419	0.999999999678419	1
up	TCF21; ID1; FOXF1; ERRFI1;	GO:0060426~lung vasculature development	4	6	66.6666666666667	0.00995713756356253	0.684365720628149	1	1	0.999999999678419	0.999999999678419	1
up	JUP; DSP; DSC2; CTNNA3;	GO:0086073~bundle of His cell-Purkinje myocyte adhesion involved in cell communication	4	6	66.6666666666667	0.00995713756356253	0.684365720628149	1	1	0.999999999678419	0.999999999678419	1
up	JCHAIN; IGKV3-20; IGHA2; LTF; CTSG; H2BFS; DEFB1; RNASE6; RNASE7;	GO:0019731~antibacterial humoral response	9	31	29.0322580645161	0.00996043841031291	0.684365720628149	1	1	0.999999999678419	0.999999999678419	1
down	CEP290; ONECUT2; NOTCH1; ARMC9; DZIP1; DNAH5; CFAP54;	GO:0060271~cilium assembly	7	187	3.74331550802139	0.0100020864715541	0.0505465885641939	1	1	0.879474055608035	0.969996934992558	0.429187017190334
up	EDN3; EDN2; AVPR1A; NMU; RGS4; KCNQ1; RYR2;	GO:0010460~positive regulation of heart rate	7	20	35	0.0100933911990301	0.684365720628149	1	1	0.999999999678419	0.999999999678419	1
up	CCL22; EREG; F13A1; POMC; IL2RA; IGHG4; ANXA1; CCL2; MUC1; IL1RN; EDN2; IL10; PTPRZ1; CD80; FLT3; CCR2; TEC; FASLG; CEBPA; RORC; CCL11; CCR5; YWHAZ; CX3CL1; LCN2; IL18; IRF4; BATF; IL20RB; IL17REL; IL22RA1; IL1F10; IL22RA2; IL17F; CCL19; IL1RL2; IL23A; IL26; IL36B; IL36G; IL36RN; IL36A; IL20RA;	GO:0019221~cytokine-mediated signaling pathway	43	278	15.4676258992806	0.0101184246133181	0.684365720628149	1	1	0.999999999678419	0.999999999678419	1
down	SHH; SIX1; SIX4;	GO:0034504~protein localization to nucleus	3	34	8.82352941176471	0.0102292504535642	0.0514095050368463	1	1	0.881901175566693	0.969996934992558	0.436513971540809
down	PDGFA; COL5A2; ITGA3;	GO:0043588~skin development	3	34	8.82352941176471	0.0102292504535642	0.0514095050368463	1	1	0.881901175566693	0.969996934992558	0.436513971540809
down	RBFOX2; DSCAM; MAP6;	GO:0048813~dendrite morphogenesis	3	34	8.82352941176471	0.0102292504535642	0.0514095050368463	1	1	0.881901175566693	0.969996934992558	0.436513971540809
up	GGCT; GGT5; GGT6; CHAC2; MGST2; CHAC1;	GO:0006750~glutathione biosynthetic process	6	15	40	0.0103260955004029	0.684365720628149	1	1	0.999999999678419	0.999999999678419	1
up	PLA2G4B; PLA2G4D; GDPD3; PLA2G4A; PLA2G4F; PLA2G4E;	GO:0046475~glycerophospholipid catabolic process	6	15	40	0.0103260955004029	0.684365720628149	1	1	0.999999999678419	0.999999999678419	1
down	ITGA2; ITGA3; TGFB2;	GO:0010634~positive regulation of epithelial cell migration	3	35	8.57142857142857	0.011007305251062	0.0538353712994695	1	1	0.894086647685778	0.969996934992558	0.457111806823711
down	NTRK1; APP; NTRK2;	GO:1990090~cellular response to nerve growth factor stimulus	3	35	8.57142857142857	0.011007305251062	0.0538353712994695	1	1	0.894086647685778	0.969996934992558	0.457111806823711
down	GJC1; PXN; MYL7; CALD1; KCNJ12;	GO:0006936~muscle contraction	5	106	4.71698113207547	0.0116913059518582	0.0570786258435362	1	1	0.902809444248566	0.969996934992558	0.484650020248129
down	TERT; SHH; SFRP1;	GO:0030177~positive regulation of Wnt signaling pathway	3	36	8.33333333333333	0.011818634869259	0.0575974112879755	1	1	0.90516051050963	0.969996934992558	0.489054985722265
down	TNFSF4; TWIST1; PROX1; FOXA2;	GO:0043433~negative regulation of DNA-binding transcription factor activity	4	69	5.79710144927536	0.0121752109284867	0.0579695387919027	1	1	0.910090165573151	0.969996934992558	0.492214690421667
up	CLDN5; CLDN4; CLDN7; CLDN1; CLDN8; CLDN17; CLDN10;	GO:0016338~calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules	7	21	33.3333333333333	0.0123978035994067	0.752330556390082	1	1	0.999999999678419	0.999999999678419	1
up	CYP2C9; CYP2C19; CYP4A11; CYP2G1P; CYP2F1; CYP2C18; CYP2A6;	GO:0019373~epoxygenase P450 pathway	7	21	33.3333333333333	0.0123978035994067	0.752330556390082	1	1	0.999999999678419	0.999999999678419	1
down	HTRA1; E2F7; NODAL;	GO:0001890~placenta development	3	37	8.10810810810811	0.0126634587396605	0.0600032862984951	1	1	0.915348464307574	0.969996934992558	0.509483076891788
down	ALOX15; ITGA3; EGFLAM;	GO:0010811~positive regulation of cell-substrate adhesion	3	37	8.10810810810811	0.0126634587396605	0.0600032862984951	1	1	0.915348464307574	0.969996934992558	0.509483076891788
up	S100A8; S100A9; SELE; CX3CL1; FUT7;	GO:0002523~leukocyte migration involved in inflammatory response	5	11	45.4545454545455	0.0127127788121586	0.752330556390082	1	1	0.999999999678419	0.999999999678419	1
down	TERT; APP; CSF3; CAV1;	GO:0032092~positive regulation of protein binding	4	70	5.71428571428571	0.0127500650464594	0.0602049703575473	1	1	0.918004683345075	0.969996934992558	0.511195560012375
down	WNT7A; SHH; SFRP1; FZD8;	GO:0060070~canonical Wnt signaling pathway	4	70	5.71428571428571	0.0127500650464594	0.0602049703575473	1	1	0.918004683345075	0.969996934992558	0.511195560012375
up	PGC; KLK7; KLK5;	GO:0002803~positive regulation of antibacterial peptide production	3	3	100	0.0130055872026731	0.752330556390082	1	1	0.999999999678419	0.999999999678419	1
up	CCL21; IGF1; CCL19;	GO:0010560~positive regulation of glycoprotein biosynthetic process	3	3	100	0.0130055872026731	0.752330556390082	1	1	0.999999999678419	0.999999999678419	1
up	PAX6; NKX6-1; NKX6-2;	GO:0021912~regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification	3	3	100	0.0130055872026731	0.752330556390082	1	1	0.999999999678419	0.999999999678419	1
up	TGM1; TGM3; HRNR;	GO:0043163~cell envelope organization	3	3	100	0.0130055872026731	0.752330556390082	1	1	0.999999999678419	0.999999999678419	1
up	PTGES; EDN2; PLA2G4A; PTGIS; PLA2G4F; MGST1;	GO:0001516~prostaglandin biosynthetic process	6	16	37.5	0.0131001898144536	0.752330556390082	1	1	0.999999999678419	0.999999999678419	1
up	TYROBP; CTLA4; IL10; FCGR2B; MNDA; CD300A;	GO:0030889~negative regulation of B cell proliferation	6	16	37.5	0.0131001898144536	0.752330556390082	1	1	0.999999999678419	0.999999999678419	1
down	SLC4A3; SLC9A3; SLC9A5;	GO:0098656~anion transmembrane transport	3	38	7.89473684210526	0.0135419722547876	0.0634832947765025	1	1	0.926320920376273	0.969996934992558	0.539031548923213
down	NTRK1; RAG1; IL11; POLM;	GO:0030183~B cell differentiation	4	72	5.55555555555556	0.0139510429751231	0.0634832947765025	1	1	0.930487281337486	0.969996934992558	0.539031548923213
down	BMPR1B; FAM20C; OSR1;	GO:0030501~positive regulation of bone mineralization	3	39	7.69230769230769	0.0144543474845529	0.0656448272803448	1	1	0.934951239510214	0.969996934992558	0.557384947525096
up	PTGES; CXCL13; S100A8; CCL11;	GO:0002544~chronic inflammatory response	4	7	57.1428571428571	0.0145063529718557	0.752330556390082	1	1	0.999999999678419	0.999999999678419	1
up	SLC22A3; POMC; SCTR; HTR4;	GO:0032098~regulation of appetite	4	7	57.1428571428571	0.0145063529718557	0.752330556390082	1	1	0.999999999678419	0.999999999678419	1
up	S100A8; SERPINB3; CX3CL1; HILPDA;	GO:0035425~autocrine signaling	4	7	57.1428571428571	0.0145063529718557	0.752330556390082	1	1	0.999999999678419	0.999999999678419	1
up	CD1C; CD1A; CD1B; CD1E;	GO:0048007~antigen processing and presentation, exogenous lipid antigen via MHC class Ib	4	7	57.1428571428571	0.0145063529718557	0.752330556390082	1	1	0.999999999678419	0.999999999678419	1
up	KLF4; IFNG; PAX6; FOXC1;	GO:1904798~positive regulation of core promoter binding	4	7	57.1428571428571	0.0145063529718557	0.752330556390082	1	1	0.999999999678419	0.999999999678419	1
down	TNFRSF10B; LOX; CASP6; BCAR1; BCL2L15; RTKN; CARD10;	GO:0042981~regulation of apoptotic process	7	202	3.46534653465347	0.0145708710452015	0.0660642809910131	1	1	0.934951239510214	0.969996934992558	0.560946495238697
up	KRT16; KRT3; KRT6C; EVPLL; PPL; DSP; EVPL;	GO:0045104~intermediate filament cytoskeleton organization	7	22	31.8181818181818	0.0150577846228946	0.752330556390082	1	1	0.999999999678419	0.999999999678419	1
down	CAV1; TNS4; NRCAM; CCDC68;	GO:0008104~protein localization	4	74	5.40540540540541	0.0152214303940181	0.0687857697475134	1	1	0.94227886896356	0.969996934992558	0.584054437335244
down	TNFRSF10B; THBS1; ALOX15; SRPX;	GO:0034976~response to endoplasmic reticulum stress	4	74	5.40540540540541	0.0152214303940181	0.0687857697475134	1	1	0.94227886896356	0.969996934992558	0.584054437335244
down	TERT; SLIT3; APP; NOTCH1; TGFB2; SFRP1; ROBO1;	GO:0010629~negative regulation of gene expression	7	204	3.43137254901961	0.0152762635052245	0.0689196442628445	1	1	0.94227886896356	0.969996934992558	0.585191155075153
down	ITGA2; DZIP1; PDZD7;	GO:0045184~establishment of protein localization	3	40	7.5	0.0154007338774753	0.0691389267997004	1	1	0.94227886896356	0.969996934992558	0.587053065455031
down	KRT8; FHOD3; SIX4;	GO:0045214~sarcomere organization	3	40	7.5	0.0154007338774753	0.0691389267997004	1	1	0.94227886896356	0.969996934992558	0.587053065455031
down	APP; GRIK2; SCN2A;	GO:0051402~neuron apoptotic process	3	40	7.5	0.0154007338774753	0.0691389267997004	1	1	0.94227886896356	0.969996934992558	0.587053065455031
up	IGKV1-5; IGKV3-20; IGKV3-15; IGLV1-47; IGLV2-14; IGLV2-23; IGLV3-1; IGLV3-25; IGHV3-23; IGKC; IGHG2; IGHG3; IGHG4; C1QA; C1QB; C1QC; C9; IGKV3-11; IGKV4-1; IGLC2; IGLC3; IGLV3-21; TRDC; IGHV3-21; TRBC2; TRBC1; IGHA2;	GO:0006958~complement activation, classical pathway	27	161	16.7701863354037	0.015840214331417	0.752330556390082	1	1	0.999999999678419	0.999999999678419	1
up	RRP15; WDR12; MRPL1; SNU13; RSL1D1; MAK16;	GO:0000470~maturation of LSU-rRNA	6	17	35.2941176470588	0.0163561178743252	0.752330556390082	1	1	0.999999999678419	0.999999999678419	1
up	ALOX15B; APOB; LPL; PLA2G2A; PLA2G5; IL18;	GO:0010744~positive regulation of macrophage derived foam cell differentiation	6	17	35.2941176470588	0.0163561178743252	0.752330556390082	1	1	0.999999999678419	0.999999999678419	1
down	PDPN; SFXN5; SLC38A5;	GO:0006865~amino acid transport	3	41	7.31707317073171	0.0163812589464192	0.0714296044011324	1	1	0.950485813951307	0.969996934992558	0.606503024691247
down	CPS1; FSTL1; TBC1D5;	GO:0042594~response to starvation	3	41	7.31707317073171	0.0163812589464192	0.0714296044011324	1	1	0.950485813951307	0.969996934992558	0.606503024691247
down	NTRK1; APP; IGF1R;	GO:1904646~cellular response to amyloid-beta	3	41	7.31707317073171	0.0163812589464192	0.0714296044011324	1	1	0.950485813951307	0.969996934992558	0.606503024691247
down	TBX1; NTRK1; APP; NTRK2; PGF; VEGFC;	GO:0001934~positive regulation of protein phosphorylation	6	161	3.72670807453416	0.0168508687120825	0.0732986421690101	1	1	0.956527037345065	0.969996934992558	0.622372874020302
down	CDH13; PDPN; RTKN; VANGL2;	GO:0007266~Rho protein signal transduction	4	77	5.19480519480519	0.0172597179495941	0.0732986421690101	1	1	0.959740454043873	0.969996934992558	0.622372874020302
down	PDGFA; FSCN1; DLC1; VANGL2;	GO:0032956~regulation of actin cytoskeleton organization	4	77	5.19480519480519	0.0172597179495941	0.0732986421690101	1	1	0.959740454043873	0.969996934992558	0.622372874020302
down	SLC26A4; SLC4A3; SLC26A6;	GO:0015701~bicarbonate transport	3	42	7.14285714285714	0.0173960289391517	0.0732986421690101	1	1	0.959740454043873	0.969996934992558	0.622372874020302
down	ISL1; SOX4; NLGN2;	GO:0032024~positive regulation of insulin secretion	3	42	7.14285714285714	0.0173960289391517	0.0732986421690101	1	1	0.959740454043873	0.969996934992558	0.622372874020302
down	MMP14; DLX1; DLX2;	GO:0045746~negative regulation of Notch signaling pathway	3	42	7.14285714285714	0.0173960289391517	0.0732986421690101	1	1	0.959740454043873	0.969996934992558	0.622372874020302
down	LYPD6; PCSK9; DKK3;	GO:2000272~negative regulation of signaling receptor activity	3	42	7.14285714285714	0.0173960289391517	0.0732986421690101	1	1	0.959740454043873	0.969996934992558	0.622372874020302
up	CLDN1; ASS1; GBA; APOB; CCL2; PCK1; CEBPA; LCN2; HYAL1; OCLN; NPNT; XCL2; CCL22; CCL8; CX3CL1; CCL17; CCL14; CCL21; CCL19; CCL18; CCL11; XCL1;	GO:0071356~cellular response to tumor necrosis factor	22	125	17.6	0.0178142810364711	0.752330556390082	1	1	0.999999999678419	0.999999999678419	1
down	SERPINE1; ITGA2; MDK; TNFSF4;	GO:0050729~positive regulation of inflammatory response	4	78	5.12820512820513	0.0179750774670122	0.0732986421690101	1	1	0.962070399752274	0.969996934992558	0.622372874020302
up	IGLV1-50; TRBV19; TRBV20-1; TRGV2; IGKV1D-8; IGLV5-52; TRAV19; TRAV13-1; IGKV3D-7; TRBV27; TRBV7-2; TRBV28; LILRA1; JCHAIN; HLA-DQA2; TRGV3; TRGC2; ANXA1; CD3D; TRBV7-9; HLA-DQB2; CD1A; CD3G; TRGC1; CD8B; CD1E; CTLA4; HLA-DMB; CD1B; CD1C; CD79B; ARG2; SLAMF1; TRAT1; VTCN1; NLRP10; SKAP1; CLEC10A; ZNF683; LILRB2; LILRB1; FCAMR; FCGR1B; SIGLEC10; CD209; CD84; LAMP3; SIT1; IFNG; TEC;	GO:0002250~adaptive immune response	50	347	14.4092219020173	0.0180004686644166	0.752330556390082	1	1	0.999999999678419	0.999999999678419	1
down	TBX3; TBX1; ANTXR1;	GO:0001568~blood vessel development	3	43	6.97674418604651	0.0184451294929513	0.0732986421690101	1	1	0.962769071066546	0.969996934992558	0.622372874020302
down	FSD1; DYNC1H1; KATNAL1;	GO:0031122~cytoplasmic microtubule organization	3	43	6.97674418604651	0.0184451294929513	0.0732986421690101	1	1	0.962769071066546	0.969996934992558	0.622372874020302
up	CD5L; RAET1L; CD300LG; IDO2; CD300LF; IRF6; CTLA4; IRF8; IRF4;	GO:0002376~immune system process	9	35	25.7142857142857	0.0184518766672662	0.752330556390082	1	1	0.999999999678419	0.999999999678419	1
down	KRT8; TNFSF4; CDIP1; EDA2R; TNFRSF12A;	GO:0033209~tumor necrosis factor-mediated signaling pathway	5	120	4.16666666666667	0.0186625076511302	0.0732986421690101	1	1	0.963495689233388	0.969996934992558	0.622372874020302
down	BCAR1; FAT1; FHOD3; SAMD14; CORO6;	GO:0007015~actin filament organization	5	121	4.13223140495868	0.0192455062542602	0.0732986421690101	1	1	0.964251965284592	0.969996934992558	0.622372874020302
down	PTHLH; ALOX15; LOX;	GO:0030282~bone mineralization	3	44	6.81818181818182	0.0195286262762927	0.0732986421690101	1	1	0.965039752837929	0.969996934992558	0.622372874020302
up	CES2; PTGES; HPGDS; GSTA1; HPGD; AKR1C2;	GO:0006693~prostaglandin metabolic process	6	18	33.3333333333333	0.0201293131625786	0.752330556390082	1	1	0.999999999678419	0.999999999678419	1
up	KLF4; SPINK5; OVOL1; OVOL2;	GO:0009913~epidermal cell differentiation	4	8	50	0.0201793430303434	0.752330556390082	1	1	0.999999999678419	0.999999999678419	1
up	AQP1; SCNN1A; SCNN1B; SCNN1G;	GO:0050891~multicellular organismal water homeostasis	4	8	50	0.0201793430303434	0.752330556390082	1	1	0.999999999678419	0.999999999678419	1
down	SH3PXD2B; MMP16; CAV1; MMP17;	GO:0043085~positive regulation of catalytic activity	4	81	4.93827160493827	0.0202306707332307	0.0732986421690101	1	1	0.966718082842864	0.969996934992558	0.622372874020302
down	APP; SH3RF2; EDA2R; WNT7A;	GO:0046330~positive regulation of JNK cascade	4	81	4.93827160493827	0.0202306707332307	0.0732986421690101	1	1	0.966718082842864	0.969996934992558	0.622372874020302
down	ITGB4; SRPX; TBC1D5; EVA1A; TIGAR;	GO:0006914~autophagy	5	123	4.0650406504065	0.0204470731616706	0.0732986421690101	1	1	0.966718082842864	0.969996934992558	0.622372874020302
down	SERPINE2; NTRK2; SHANK3;	GO:0060291~long-term synaptic potentiation	3	45	6.66666666666667	0.0206465656146979	0.0732986421690101	1	1	0.96761319217883	0.969996934992558	0.622372874020302
up	EDN3; EDN2; EDNRB;	GO:0014826~vein smooth muscle contraction	3	4	75	0.0211951609395046	0.752330556390082	1	1	0.999999999678419	0.999999999678419	1
up	PAX6; NKX6-1; NKX6-2;	GO:0021913~regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification	3	4	75	0.0211951609395046	0.752330556390082	1	1	0.999999999678419	0.999999999678419	1
up	CIDEA; APOA4; LY6D;	GO:0035634~response to stilbenoid	3	4	75	0.0211951609395046	0.752330556390082	1	1	0.999999999678419	0.999999999678419	1
up	PLD1; TNFAIP8L3; ADAP2;	GO:0048017~inositol lipid-mediated signaling	3	4	75	0.0211951609395046	0.752330556390082	1	1	0.999999999678419	0.999999999678419	1
up	TJP1; ANGPT1; OCLN;	GO:1905605~positive regulation of maintenance of permeability of blood-brain barrier	3	4	75	0.0211951609395046	0.752330556390082	1	1	0.999999999678419	0.999999999678419	1
up	GTPBP4; WDR12; RPF2; RPL7L1; DDX18;	GO:0000463~maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)	5	13	38.4615384615385	0.0213263642083851	0.752330556390082	1	1	0.999999999678419	0.999999999678419	1
up	PTGES; NUPR1; S100A8; HP; HPR;	GO:0002526~acute inflammatory response	5	13	38.4615384615385	0.0213263642083851	0.752330556390082	1	1	0.999999999678419	0.999999999678419	1
down	PLAU; SERPINE2; ITGA2; TFPI2; SHH; EHD2;	GO:0007596~blood coagulation	6	171	3.50877192982456	0.0217325468509953	0.0732986421690101	1	1	0.969528309827873	0.969996934992558	0.622372874020302
up	KLF4; IFNG; NPR3; NOS3; AIF1; PPARD; CTNNBIP1; NDRG2;	GO:0048662~negative regulation of smooth muscle cell proliferation	8	30	26.6666666666667	0.0217394134663402	0.752330556390082	1	1	0.999999999678419	0.999999999678419	1
down	FOXC2; SEMA3C; TBX18;	GO:0001756~somitogenesis	3	46	6.52173913043478	0.0217989751026676	0.0732986421690101	1	1	0.969528309827873	0.969996934992558	0.622372874020302
down	TGFB2; SHH; SIX1;	GO:0048839~inner ear development	3	46	6.52173913043478	0.0217989751026676	0.0732986421690101	1	1	0.969528309827873	0.969996934992558	0.622372874020302
down	CADM1; TENM2; TENM3;	GO:0007157~heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules	3	47	6.38297872340426	0.022985864202772	0.0732986421690101	1	1	0.969996934992558	0.969996934992558	0.622372874020302
down	SLC4A3; KCNJ12; KCNIP3;	GO:0061337~cardiac conduction	3	47	6.38297872340426	0.022985864202772	0.0732986421690101	1	1	0.969996934992558	0.969996934992558	0.622372874020302
down	NTRK1; RET; AXL; EPHB4; NTRK2;	GO:0018108~peptidyl-tyrosine phosphorylation	5	127	3.93700787401575	0.0229947458126558	0.0732986421690101	1	1	0.969996934992558	0.969996934992558	0.622372874020302
up	RAMP3; ATP2C2; NFASC; ATP1B1; JUP; ATP1B3; EMP2; CAV3; RAB10; RAB11A; ANK2; DLG1; MAP7; SKAP1; DPP10; MRAP; KCNB2; NKD2; TESC; CRB3; FAM126A; EFR3B; PKP3; RAB3C;	GO:0072659~protein localization to plasma membrane	24	144	16.6666666666667	0.0232057217751985	0.752330556390082	1	1	0.999999999678419	0.999999999678419	1
down	LPXN; CLDN14; LAMC1; TEAD2; CARD10;	GO:0065003~protein-containing complex assembly	5	128	3.90625	0.0236622232871024	0.0732986421690101	1	1	0.969996934992558	0.969996934992558	0.622372874020302
down	APP; GDNF; FOXA2;	GO:0008344~adult locomotory behavior	3	48	6.25	0.024207224830471	0.0732986421690101	1	1	0.969996934992558	0.969996934992558	0.622372874020302
down	LHX1; CNTN1; CDK5R2;	GO:0021549~cerebellum development	3	48	6.25	0.024207224830471	0.0732986421690101	1	1	0.969996934992558	0.969996934992558	0.622372874020302
down	ITGA2; MDK; FRMD5;	GO:0045785~positive regulation of cell adhesion	3	48	6.25	0.024207224830471	0.0732986421690101	1	1	0.969996934992558	0.969996934992558	0.622372874020302
down	APOD; ALOX15; NR2F2; HSPG2; LIPG;	GO:0006629~lipid metabolic process	5	130	3.84615384615385	0.0250343533526183	0.0755451678433315	1	1	0.969996934992558	0.969996934992558	0.6414479427953
up	CASQ2; ATP8B1; ATP10A; ATP2C2; ATP6V1G1; ATP1B1; ATP4A; CHRNA7; SCNN1A; SCNN1B; SCNN1G; ATP12A; ATP1B3; GRIK3; FXYD3; GRIK4; ATP13A4; ATP6V1C2; RYR2; TTYH1; ATP6V0A4; ASIC5; ATP6V1D; CLCA3P; CHRNA2; GLRA1; GABRD; GABRE; GABRA4; HTR3B; HTR3A; GABRB2;	GO:0034220~ion transmembrane transport	32	208	15.3846153846154	0.0251045101854462	0.752330556390082	1	1	0.999999999678419	0.999999999678419	1
up	HOXB1; FST; BMP5; SOSTDC1; GRHL3; SHROOM3; FOXJ1; TBX5;	GO:0007389~pattern specification process	8	31	25.8064516129032	0.0251821732063851	0.752330556390082	1	1	0.999999999678419	0.999999999678419	1
up	EGFR; ASS1; EIF4E; SRD5A1; AQP1; METTL21C; ERRFI1; PCK1;	GO:0071549~cellular response to dexamethasone stimulus	8	31	25.8064516129032	0.0251821732063851	0.752330556390082	1	1	0.999999999678419	0.999999999678419	1
down	DSCAM; APP; ETV5; RASD2;	GO:0007626~locomotory behavior	4	87	4.59770114942529	0.0252441576541473	0.0760104923198665	1	1	0.969996934992558	0.969996934992558	0.645398975491721
down	ITGA2; ITGB6; AXL; EFNB3;	GO:0046718~viral entry into host cell	4	87	4.59770114942529	0.0252441576541473	0.0760104923198665	1	1	0.969996934992558	0.969996934992558	0.645398975491721
up	ADH1A; CYP2A6; CYP2C9; UGT1A1; CYP2C19; TPMT; UGT1A7;	GO:0017144~drug metabolic process	7	25	28	0.0254261838839527	0.752330556390082	1	1	0.999999999678419	0.999999999678419	1
down	WNT7A; SYT1; GAD1;	GO:0007269~neurotransmitter secretion	3	49	6.12244897959184	0.0254630319251256	0.0765851807296956	1	1	0.969996934992558	0.969996934992558	0.650278608547771
down	WNT7A; PRICKLE2; SMURF2; GPC6;	GO:0060071~Wnt signaling pathway, planar cell polarity pathway	4	88	4.54545454545455	0.0261459078688131	0.0785526506739945	1	1	0.969996934992558	0.969996934992558	0.666984237568272
up	ASPDH; SDR42E2; KDM4E; PIR; PRODH; AKR1B10; FMO6P; ALDH1L1; BBOX1; TM7SF2; CH25H; LIPF; GSTA1; SOD3; MGST1; CYP2C9; IMPDH2; CYP4B1; HPGD; AOC1; NOS3; FMO3; CYP2C19; ADH7; ALDH3B2; TDO2; AKR1C2; HCCS; HSD11B2; BDH1; CYP4A11; PRDX1; SELENBP1; DHCR24; PTGIS; ALDH1L2; CYP4A22; TXNDC8; CYB5R2; CYP4F22; IYD; DHRS11; IDO2; CYP4X1; CYP4Z2P; SDR16C5; OGFOD1; FADS6; RDH13; SDR9C7; RTN4IP1; DIO2; COX4I2; DHRS1; RDH12; DHRS9; HSD3B7; SRD5A3; MTHFD2L; L2HGDH; CYP4F11; STAB1; CYP39A1; TECR; ACAD8; CYP2G1P; CYP2A6; CYP2F1; CYP2C18; PTGES;	GO:0055114~oxidation-reduction process	70	526	13.3079847908745	0.0265825948410141	0.752330556390082	1	1	0.999999999678419	0.999999999678419	1
down	ELFN1; ELFN2; SH3RF2;	GO:0010923~negative regulation of phosphatase activity	3	50	6	0.0267532440089746	0.0794173388930907	1	1	0.969996934992558	0.969996934992558	0.67432623567527
up	ADRA2A; NOS3; CAV3; LILRB2; LILRB1;	GO:0051926~negative regulation of calcium ion transport	5	14	35.7142857142857	0.0267756156994591	0.752330556390082	1	1	0.999999999678419	0.999999999678419	1
up	SCNN1A; SCNN1B; SCNN1G; CYP4A11; TFAP2B;	GO:0055078~sodium ion homeostasis	5	14	35.7142857142857	0.0267756156994591	0.752330556390082	1	1	0.999999999678419	0.999999999678419	1
up	CCR2; PLA2G4A; NLRP10; IL23A;	GO:0002827~positive regulation of T-helper 1 type immune response	4	9	44.4444444444444	0.0270393240656397	0.752330556390082	1	1	0.999999999678419	0.999999999678419	1
up	HAAO; TDO2; IDO2; ACMSD;	GO:0006569~tryptophan catabolic process	4	9	44.4444444444444	0.0270393240656397	0.752330556390082	1	1	0.999999999678419	0.999999999678419	1
up	SASH1; LY86; SCIMP; CD180;	GO:0031666~positive regulation of lipopolysaccharide-mediated signaling pathway	4	9	44.4444444444444	0.0270393240656397	0.752330556390082	1	1	0.999999999678419	0.999999999678419	1
up	APOA4; LPL; CETP; APOA1;	GO:0034372~very-low-density lipoprotein particle remodeling	4	9	44.4444444444444	0.0270393240656397	0.752330556390082	1	1	0.999999999678419	0.999999999678419	1
up	ALOX15B; FABP5; PTGIS; CITED2;	GO:0035360~positive regulation of peroxisome proliferator activated receptor signaling pathway	4	9	44.4444444444444	0.0270393240656397	0.752330556390082	1	1	0.999999999678419	0.999999999678419	1
down	TBX3; LIF; NODAL;	GO:0019827~stem cell population maintenance	3	51	5.88235294117647	0.0280778037327649	0.0828098332312614	1	1	0.969996934992558	0.969996934992558	0.703131632185569
down	CSF3; ALOX15; CCL26;	GO:0030838~positive regulation of actin filament polymerization	3	51	5.88235294117647	0.0280778037327649	0.0828098332312614	1	1	0.969996934992558	0.969996934992558	0.703131632185569
down	ELFN1; ELFN2; SH3RF2;	GO:0032515~negative regulation of phosphoprotein phosphatase activity	3	51	5.88235294117647	0.0280778037327649	0.0828098332312614	1	1	0.969996934992558	0.969996934992558	0.703131632185569
down	SLC26A4; SIX1; SIX4;	GO:0032880~regulation of protein localization	3	51	5.88235294117647	0.0280778037327649	0.0828098332312614	1	1	0.969996934992558	0.969996934992558	0.703131632185569
down	TBX1; GAD1; SHANK3;	GO:0035176~social behavior	3	51	5.88235294117647	0.0280778037327649	0.0828098332312614	1	1	0.969996934992558	0.969996934992558	0.703131632185569
down	WTIP; HOXC6; CDYL2;	GO:1903507~negative regulation of nucleic acid-templated transcription	3	51	5.88235294117647	0.0280778037327649	0.0828098332312614	1	1	0.969996934992558	0.969996934992558	0.703131632185569
down	SCG5; NOTCH1; SNCB;	GO:0043086~negative regulation of catalytic activity	3	52	5.76923076923077	0.0294366384089547	0.0862591312005168	1	1	0.969996934992558	0.969996934992558	0.732419343757742
down	TGFB2; GRIK2; PCSK9;	GO:0043525~positive regulation of neuron apoptotic process	3	52	5.76923076923077	0.0294366384089547	0.0862591312005168	1	1	0.969996934992558	0.969996934992558	0.732419343757742
down	SH3PXD2B; SNAI2; SFRP1;	GO:0045600~positive regulation of fat cell differentiation	3	52	5.76923076923077	0.0294366384089547	0.0862591312005168	1	1	0.969996934992558	0.969996934992558	0.732419343757742
down	CAV1; BVES; TIGAR;	GO:0002931~response to ischemia	3	53	5.66037735849057	0.0308296605327314	0.0884266805780382	1	1	0.969996934992558	0.969996934992558	0.750823831149996
up	LTF; RARRES2; IL36RN;	GO:0019732~antifungal humoral response	3	5	60	0.0315933487791686	0.752330556390082	1	1	0.999999999678419	0.999999999678419	1
up	ATP8B1; PLD1; KLF5;	GO:0032534~regulation of microvillus assembly	3	5	60	0.0315933487791686	0.752330556390082	1	1	0.999999999678419	0.999999999678419	1
up	CNR2; CD300LF; CD84;	GO:0033004~negative regulation of mast cell activation	3	5	60	0.0315933487791686	0.752330556390082	1	1	0.999999999678419	0.999999999678419	1
up	IL10; IL18; BCL6B;	GO:0042092~type 2 immune response	3	5	60	0.0315933487791686	0.752330556390082	1	1	0.999999999678419	0.999999999678419	1
up	EGFR; DUOXA1; DUOXA2;	GO:0042743~hydrogen peroxide metabolic process	3	5	60	0.0315933487791686	0.752330556390082	1	1	0.999999999678419	0.999999999678419	1
up	HPGD; FOXF1; TFAP2B;	GO:0097070~ductus arteriosus closure	3	5	60	0.0315933487791686	0.752330556390082	1	1	0.999999999678419	0.999999999678419	1
up	HSPA2; RGN; RYR2;	GO:1901896~positive regulation of ATPase-coupled calcium transmembrane transporter activity	3	5	60	0.0315933487791686	0.752330556390082	1	1	0.999999999678419	0.999999999678419	1
down	ETV5; DHRS2; PRKD1; GPX8;	GO:0034599~cellular response to oxidative stress	4	94	4.25531914893617	0.0319597283160136	0.0884266805780382	1	1	0.969996934992558	0.969996934992558	0.750823831149996
up	MPZL2; CDH16; CEACAM5; DSG3; CEACAM6; DSG1; DSC2; PCDH1; DSC3; IGSF11; CADM3; CLSTN2; ROBO2; CD84; CDH22; PCDHGB4; PCDHA4; IGSF9B; PCDHB5; PCDHGC4; NECTIN4; CNTN4; CDH19; ROBO4; IGSF21; CDH12;	GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules	26	165	15.7575757575758	0.0322048856217153	0.752330556390082	1	1	0.999999999678419	0.999999999678419	1
down	FBXL7; FBXO2; FBXL2; LRRC29;	GO:0031146~SCF-dependent proteasomal ubiquitin-dependent protein catabolic process	4	95	4.21052631578947	0.032996395324788	0.0884266805780382	1	1	0.969996934992558	0.969996934992558	0.750823831149996
up	CTSV; SEMA3A; NRTN; AFG3L2; NTF3;	GO:0021675~nerve development	5	15	33.3333333333333	0.0330356086899235	0.752330556390082	1	1	0.999999999678419	0.999999999678419	1
up	PGR; TACSTD2; EDNRB; SERPINB5; HES5;	GO:0050678~regulation of epithelial cell proliferation	5	15	33.3333333333333	0.0330356086899235	0.752330556390082	1	1	0.999999999678419	0.999999999678419	1
up	KLF4; ID1; CASR; KLF5; KLF15;	GO:1901653~cellular response to peptide	5	15	33.3333333333333	0.0330356086899235	0.752330556390082	1	1	0.999999999678419	0.999999999678419	1
up	IL18RAP; IGF1; GLUL; PAX1; LTK; EMP2; DLX5; PPARD; PRDX1; FOXC1; IL18; FAM83B; GRHL2; OGFOD1; ALKBH3; CITED2; GNL3; SDCBP2; FAM83D; PAK1IP1; PAK5; ZPR1; TACC2;	GO:0008283~cell population proliferation	23	142	16.1971830985916	0.033171348005743	0.752330556390082	1	1	0.999999999678419	0.999999999678419	1
down	SIPA1L3; FGD1; SYDE1; ARHGAP22; DLC1;	GO:0051056~regulation of small GTPase mediated signal transduction	5	141	3.54609929078014	0.0334879370459833	0.0884266805780382	1	1	0.969996934992558	0.969996934992558	0.750823831149996
down	ADAMTS3; MMP14; MMP16;	GO:0016485~protein processing	3	55	5.45454545454545	0.033717846057299	0.0884266805780382	1	1	0.969996934992558	0.969996934992558	0.750823831149996
down	TGFB1I1; ONECUT2; WNT7A;	GO:0045165~cell fate commitment	3	55	5.45454545454545	0.033717846057299	0.0884266805780382	1	1	0.969996934992558	0.969996934992558	0.750823831149996
up	APOA1; APOC3; LPL; CETP; IL18; GPIHBP1; APOA4;	GO:0070328~triglyceride homeostasis	7	27	25.9259259259259	0.0345537043355666	0.752330556390082	1	1	0.999999999678419	0.999999999678419	1
up	CYP2F1; CYP2C19; CYP2A6; CYP2C9; CYP2G1P; CYP2C18;	GO:0006082~organic acid metabolic process	6	21	28.5714285714286	0.0348548917002106	0.752330556390082	1	1	0.999999999678419	0.999999999678419	1
up	GCAT; ALDH1L1; ALDH1L2; KYAT3;	GO:0009058~biosynthetic process	4	10	40	0.0351272610046673	0.752330556390082	1	1	0.999999999678419	0.999999999678419	1
up	KLF4; APOA1; IL1RN; IL10;	GO:0034115~negative regulation of heterotypic cell-cell adhesion	4	10	40	0.0351272610046673	0.752330556390082	1	1	0.999999999678419	0.999999999678419	1
up	APOA1; APOC3; APOB; APOA4;	GO:0034378~chylomicron assembly	4	10	40	0.0351272610046673	0.752330556390082	1	1	0.999999999678419	0.999999999678419	1
up	DLG1; SGCD; SEH1L; MIOS;	GO:0034629~cellular protein-containing complex localization	4	10	40	0.0351272610046673	0.752330556390082	1	1	0.999999999678419	0.999999999678419	1
up	CYP2C9; CYP2C19; CYP4A11; CYP4A22;	GO:0097267~omega-hydroxylase P450 pathway	4	10	40	0.0351272610046673	0.752330556390082	1	1	0.999999999678419	0.999999999678419	1
down	IGF1R; MFAP2; CAV1; DYNC1H1;	GO:0120162~positive regulation of cold-induced thermogenesis	4	97	4.12371134020619	0.0351281014592892	0.0884266805780382	1	1	0.969996934992558	0.969996934992558	0.750823831149996
down	PCBP4; SOX4; E2F7;	GO:0006977~DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest	3	56	5.35714285714286	0.0352127648822524	0.0884266805780382	1	1	0.969996934992558	0.969996934992558	0.750823831149996
down	PTK7; SYDE1; ANTXR1;	GO:0031532~actin cytoskeleton reorganization	3	56	5.35714285714286	0.0352127648822524	0.0884266805780382	1	1	0.969996934992558	0.969996934992558	0.750823831149996
down	BMPR1B; RET; RP1;	GO:0060041~retina development in camera-type eye	3	56	5.35714285714286	0.0352127648822524	0.0884266805780382	1	1	0.969996934992558	0.969996934992558	0.750823831149996
down	TNFRSF10B; FN1; CD44; ITGA3; L1CAM; CAV1;	GO:0050900~leukocyte migration	6	193	3.10880829015544	0.0356234649473792	0.0884266805780382	1	1	0.969996934992558	0.969996934992558	0.750823831149996
down	THBS1; ITGA2; CDH13;	GO:0048661~positive regulation of smooth muscle cell proliferation	3	57	5.26315789473684	0.0367413829623149	0.0898735610609204	1	1	0.969996934992558	0.969996934992558	0.763109176933332
down	PTPRG; PTPRK; PTPN14; PTPRU;	GO:0035335~peptidyl-tyrosine dephosphorylation	4	99	4.04040404040404	0.0373378027409499	0.0910629372825665	1	1	0.969996934992558	0.969996934992558	0.77320807474989
up	PRKAR2A; AQP1; AVPR2; RAB11A; CYP4A11; ADCY2; TFAP2B; MYO5B;	GO:0003091~renal water homeostasis	8	34	23.5294117647059	0.0377463271130347	0.752330556390082	1	1	0.999999999678419	0.999999999678419	1
up	ATP6V1G1; RAB38; RAB39A; ATP6V1C2; ATP6V0A4; SLAMF8; ATP6V1D;	GO:0090383~phagosome acidification	7	28	25	0.0398383027484804	0.752330556390082	1	1	0.999999999678419	0.999999999678419	1
down	SOX4; PRKD1; TEAD2;	GO:0060548~negative regulation of cell death	3	59	5.08474576271187	0.0398990881829175	0.0966201125705018	1	1	0.969996934992558	0.969996934992558	0.820393603063117
up	MT1X; MT1A; MT1H; MT1M; MT1G;	GO:0010273~detoxification of copper ion	5	16	31.25	0.0401323315616654	0.752330556390082	1	1	0.999999999678419	0.999999999678419	1
up	CSTA; CSTB; SERPINB3; SERPINB4; ECM1;	GO:0010466~negative regulation of peptidase activity	5	16	31.25	0.0401323315616654	0.752330556390082	1	1	0.999999999678419	0.999999999678419	1
up	ADRA2A; EDN3; EDN2; BDKRB2; ACE2;	GO:0019229~regulation of vasoconstriction	5	16	31.25	0.0401323315616654	0.752330556390082	1	1	0.999999999678419	0.999999999678419	1
up	EDN3; EDN2; KEL; EDNRB; BDKRB2;	GO:0042310~vasoconstriction	5	16	31.25	0.0401323315616654	0.752330556390082	1	1	0.999999999678419	0.999999999678419	1
down	APP; MMP14; CYGB; PXDN;	GO:0006979~response to oxidative stress	4	102	3.92156862745098	0.0407988619717505	0.0987115828590849	1	1	0.969996934992558	0.969996934992558	0.838152109031511
down	ISL1; TGFB2; SFRP1;	GO:0050680~negative regulation of epithelial cell proliferation	3	60	5	0.0415278315698211	0.100386464643582	1	1	0.969996934992558	0.969996934992558	0.852373395524894
down	WNT7A; NR2F2; MAP1B; POSTN;	GO:0032355~response to estradiol	4	103	3.88349514563107	0.0419916401419325	0.101044119988792	1	1	0.969996934992558	0.969996934992558	0.857957494154851
up	EREG; EGFR; PTPN3; BTC; EPGN; TSG101; CBLC; ERRFI1;	GO:0042059~negative regulation of epidermal growth factor receptor signaling pathway	8	35	22.8571428571429	0.0427257709797223	0.752330556390082	1	1	0.999999999678419	0.999999999678419	1
up	CD19; CD180; GAPT;	GO:0002322~B cell proliferation involved in immune response	3	6	50	0.044167076555115	0.752330556390082	1	1	0.999999999678419	0.999999999678419	1
up	DSP; GRHL1; PERP;	GO:0002934~desmosome organization	3	6	50	0.044167076555115	0.752330556390082	1	1	0.999999999678419	0.999999999678419	1
up	EDN3; EDN2; NOS3;	GO:0003100~regulation of systemic arterial blood pressure by endothelin	3	6	50	0.044167076555115	0.752330556390082	1	1	0.999999999678419	0.999999999678419	1
up	CXCL13; CH25H; HSD3B7;	GO:0035754~B cell chemotaxis	3	6	50	0.044167076555115	0.752330556390082	1	1	0.999999999678419	0.999999999678419	1
up	FOXF1; CD300A; CD84;	GO:0043305~negative regulation of mast cell degranulation	3	6	50	0.044167076555115	0.752330556390082	1	1	0.999999999678419	0.999999999678419	1
up	ANXA1; CD80; CCL19;	GO:0045627~positive regulation of T-helper 1 cell differentiation	3	6	50	0.044167076555115	0.752330556390082	1	1	0.999999999678419	0.999999999678419	1
up	DSP; TJP1; CGNL1;	GO:0150105~protein localization to cell-cell junction	3	6	50	0.044167076555115	0.752330556390082	1	1	0.999999999678419	0.999999999678419	1
up	ATP1B1; ATP1B3; ANK2;	GO:1901018~positive regulation of potassium ion transmembrane transporter activity	3	6	50	0.044167076555115	0.752330556390082	1	1	0.999999999678419	0.999999999678419	1
up	IFNG; CCL2; CCR2;	GO:1904783~positive regulation of NMDA glutamate receptor activity	3	6	50	0.044167076555115	0.752330556390082	1	1	0.999999999678419	0.999999999678419	1
up	FCGR2B; TMEM176B; LILRB1;	GO:2001199~negative regulation of dendritic cell differentiation	3	6	50	0.044167076555115	0.752330556390082	1	1	0.999999999678419	0.999999999678419	1
up	FUT3; FUT2; FUT7; FUT6;	GO:0036065~fucosylation	4	11	36.3636363636364	0.0444628974130679	0.752330556390082	1	1	0.999999999678419	0.999999999678419	1
down	GRK5; ADRA1D; ADRA1B;	GO:0007188~adenylate cyclase-modulating G protein-coupled receptor signaling pathway	3	62	4.83870967741935	0.0448841568696123	0.101044119988792	1	1	0.969996934992558	0.969996934992558	0.857957494154851
down	WNT7A; MMP14; CAV1;	GO:0043627~response to estrogen	3	62	4.83870967741935	0.0448841568696123	0.101044119988792	1	1	0.969996934992558	0.969996934992558	0.857957494154851
down	NTRK1; APP; CAV1; PRKD1; EDA2R;	GO:0051092~positive regulation of NF-kappaB transcription factor activity	5	154	3.24675324675325	0.0455221853784341	0.101044119988792	1	1	0.969996934992558	0.969996934992558	0.857957494154851
up	MT1G; AOC1; AQP1; MT1X; MT1A; MT1M; MT1H;	GO:0071280~cellular response to copper ion	7	29	24.1379310344828	0.0456227298459123	0.752330556390082	1	1	0.999999999678419	0.999999999678419	1
down	AGRN; HSPG2; GPC6;	GO:0001523~retinoid metabolic process	3	63	4.76190476190476	0.0466113298814683	0.101044119988792	1	1	0.969996934992558	0.969996934992558	0.857957494154851
up	IL2RA; IGF1; IGFBP2; CD24; IL18; IL23A;	GO:0042104~positive regulation of activated T cell proliferation	6	23	26.0869565217391	0.0477417523005403	0.752330556390082	1	1	0.999999999678419	0.999999999678419	1
up	CCL21; TRPM2; CCR2; CCR5; CCL19;	GO:0002407~dendritic cell chemotaxis	5	17	29.4117647058824	0.0480829614873135	0.752330556390082	1	1	0.999999999678419	0.999999999678419	1
up	CCL21; AIF1; CCL19; RARRES2; P2RY12;	GO:0050921~positive regulation of chemotaxis	5	17	29.4117647058824	0.0480829614873135	0.752330556390082	1	1	0.999999999678419	0.999999999678419	1
up	GRM6; ATP2C2; CCL2; LGALS3; CASR;	GO:0090280~positive regulation of calcium ion import	5	17	29.4117647058824	0.0480829614873135	0.752330556390082	1	1	0.999999999678419	0.999999999678419	1
up	ZPR1; EGFR; VIL1; ID1; FOXC1; SKAP1; GAREM1; ERRFI1; BAIAP2;	GO:0071364~cellular response to epidermal growth factor stimulus	9	43	20.9302325581395	0.0492057280677908	0.752330556390082	1	1	0.999999999678419	0.999999999678419	1
down	MAPK12; PRKD1; NEK6; MARK1; STK32B;	GO:0018105~peptidyl-serine phosphorylation	5	158	3.16455696202532	0.0496806082707041	0.104401831677252	1	1	0.969996934992558	0.969996934992558	0.886467553984605
